2009

CytoDyn Engages Litchfield Enterprises for Investor Relations
Business Wire - November 18, 2009
AURORA, Colo. - CytoDyn, Inc. (Pink Sheets: CYDY), is pleased to announce the commencement of a contract with Aurora, Colorado-based Litchfield Enterprises, Inc. (LEI), a 12-year-old investor relations/corporate development firm. CytoDyn is best known for Cytolin(R), its developmental phase immune therapy targeted at t


Bull's Eye: AHF's "No Judgemental Bullsh*t" HIV Testing Campaign Hits the Mark
Business Wire - November 17, 2009
LOS ANGELES - Never look a bull in the eye. That s lifesaving advice for a toreador in the ring at Seville. But for a driver in Los Angeles, looking into a bull s eye just might be the thing that saves your life--or the life of someone you love. That is what the folks at AIDS Healthcare Foundation (AHF) are hoping anyw


Starbucks Turns (RED) This Holiday Season
Business Wire - November 17, 2009
Starbucks Thanks Customers for Their $15 Qualifying Purchase with a Limited Time Offer CD Featuring Starbucks and (RED)(TM) Exclusive Tracks SEATTLE - Starbucks Coffee Company (Nasdaq: SBUX) celebrates the holidays and gives customers an opportunity to shop at Starbucks and give back. For a limited time, customers can


Earvin "Magic" Johnson to Speak At "Magic@50" Community Health Expo in Los Angeles
Business Wire - November 16, 2009
- Event Will Also Include Free Health Screenings, Panel Discussion Among Local Health Care Leaders - LOS ANGELES - Aetna (NYSE: AET) and Magic Johnson Enterprises (MJE) announced today that Earvin Magic Johnson will be the featured speaker at a free Magic@50 Community Health EXPO at the Nate Holden Performing Arts Cen


BIOTONE Continues Annual Support for Massage Therapy Foundation Community Service Projects
Business Wire - November 16, 2009
Projects Explore Value of Massage for Healing and for Strengthening the Human Bond SAN DIEGO - BIOTONE today announced a $15,000 donation to support three Massage Therapy Foundation funded community service projects. The donation is part of BIOTONE s ongoing support for the Massage Therapy Foundation s granting program


The Night Ministry Wins Free CITGO Gasoline for Fueling Good across Chicago
Business Wire - November 12, 2009
Local Mobile Health Clinic Recognized for Supporting At Risk Individuals CHICAGO - The Night Ministry of Chicago is the most recent grand prize winner in the Fueling Good program presented by CITGO Petroleum Corporation. In recognition of its outstanding contribution to supporting Chicago s homeless and vulnerable popu


ABL is Pleased to Announce the TherapyEdge ViroScore Suite Platform is Now Available in Brazil
Business Wire - November 12, 2009
LUXEMBOURG & SAO PAULO, Brazil - Advanced Biological Laboratories (ABL) and Centro de Genomas are pleased to announce an agency agreement whereby Centro de Genomas will provide to the private and public sectors throughout Brazil, the ABL TherapyEdge products in Portuguese language. Beginning immediately Centro de G


Bay Area High School Students Use Art to Learn About HIV/AIDS
Business Wire - November 11, 2009
Fourth Annual Don t Turn Your Back on AIDS Competition Increases Disease Awareness Among Youth OAKLAND, Calif. - Students from more than 15 Bay Area high schools are participating in the Flowers Heritage Foundation s Fourth Annual Don t Turn Your Back on AIDS art competition to highlight the impact the disease continue


Kineta, University of Washington Partner on NIH-Funded Project to Develop Vaccine Immune Boosters
Business Wire - November 10, 2009
University of Washington Will Lead $13 Million Collaborative Project SEATTLE - Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents t


AHF: California Sued for Singling Out Safety Net Providers for Drastic Cuts while Favoring Rite Aid, CVS Chains
Business Wire - November 09, 2009
Department of Health Care Services Breaks Federal and State Laws by Slashing Medi-Cal Reimbursement Rates for Drugs Dispensed by AHF and Other Safety Net Providers While Rates for CVS, Rite Aid and Other Giant National Pharmacy Chains Go Untouched--and Remain Much Higher As California Shifts Financial Burden to State s


Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV
Business Wire - November 09, 2009
Concert Earns $12 Million Milestone from GlaxoSmithKline CTP-518 has Potential as Unboosted HIV Protease Inhibitor LEXINGTON, Mass. - Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infec


Washington, D.C.: AHF Opens 'Men's Wellness Center' at 'Blair Underwood' Healthcare Center
Business Wire - November 06, 2009
Walk-In Clinic to Provide Confidential Sexual Health Services--Including HIV and STD Testing and Treatment--in One Convenient Location and At No Cost to Clients WASHINGTON - On Thursday, November 5th, AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which provides medical care and/or services to


Academy Award-Winning Actor Forest Whitaker to Keynote Symposium on Maternal and Infant Mortality in Africa
Business Wire - November 06, 2009
PASADENA, Calif. - Producer, director and Oscar-winning actor, Forest Whitaker, will provide the keynote address at a symposium on maternal and infant mortality tomorrow at the California Institute of Technology from 11 a.m. to 2 p.m. The symposium, entitled Women and Children First will explore why so many mothers and


BioAlliance Pharma: Epidemiological study on Oropharyngeal Candidiasis and results on miconazole MBT* compliance were presented at the 51st ASTRO Annual Meeting
Business Wire - November 05, 2009
ASTRO 2009 PARIS - Regulatory News: Results on epidemiologic study on OroPharyngeal Candidiasis (OPC) in oncology were presented at the 51st ASTRO (American Society for Therapeutic Radiology and Oncology) Meeting in Chicago (From November 1st to November 5th). Pr David Azria (Anticancer Center Montpellier) has presente


FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
Business Wire - November 05, 2009
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration ( FDA ) has approved a labeling update for REYATAZ(R) to include long-term data from the CASTLE Study. The CASTLE Study assessed a once-daily REYATAZ/


AllTranz Awarded $4 Million Research Grant by NIH and NIDA
Business Wire - November 03, 2009
Grant Facilitates Development of Novel Transdermal Patch for Treatment of Cancer, AIDS, and MS Patients and Marijuana Dependence LEXINGTON, Ky. - AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been a


France Innovation Scientifique & Transfert Publishes a New Report on the HIV Therapy Patent Landscape. This Report Shows a Drastic Need for Fundamental Research.
Business Wire - November 03, 2009
PARIS - IP Overview HIV Therapy 2009 ( www.frinnov.fr/en/ip-overview/sciences-de-la-vie/hiv-therapy-2.ht ml ) establishes a panorama of the patents claiming HIV and AIDS treatments and analyses the key and emerging thematic and the strategic positions of the actors involved in this sector. In order to fully analyze thi


Statement by Kathleen G. Sebelius, Secretary of Health and Human Services, on the Repeal of the HIV Entry Ban
Business Wire - November 02, 2009
WASHINGTON - Today, we will publish a rule in the Federal Register announcing that the United States will drop HIV from the list of diseases barring visitors from entering this country, effective Jan. 1, 2010. Though the United States has been a leader worldwide when it comes to ending the stigma of HIV/AIDS, we ve bee


DC AIDS Scandal Spurs AHF to Call for Congressional Investigation
Business Wire - November 2, 2009
Recent Washington Post Articles Detail Widespread Mismanagement and Corruption in District of Columbia Health Department s HIV/AIDS Administration; Millions May Have Been Misspent and Remain Unaccounted For as the District Copes with Highest AIDS Rate in the Nation WASHINGTON - On the heels of a recent series of Washin


Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation
Business Wire - October 30, 2009
US AIDS Conference SAN FRANCISCO - Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+(TM) delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).[1] Replenish+(TM) formulated by


Obama Lifts US Travel Ban on HIV-infected; Updated AIDS Bill Puts New Focus on Testing
Business Wire - October 30, 2009
President Overturns 22 Year Ban on HIV-positive Travelers to US; also Signs Ryan White CARE Act, Which Places New Emphasis on Testing, Calling for 5 Million HIV Tests Annually, Says AHF WASHINGTON - AIDS Healthcare Foundation (AHF) today lauded President Barack Obama for lifting a 22 year-old ban prohibiting HIV-positi


Research and Markets: Increased Uptake of Low-cost Rapid Diagnostic Tool Kits to Boost the Zambian Infectious Disease Testing Market
Business Wire - October 28, 2009
DUBLIN - Research and Markets (http://www.researchandmarkets.com/research/fc0207/strategic_anal ysis) has announced the addition of Frost & Sullivan s new report Strategic Analysis of the Healthcare Industry in Zambia to their offering. The infectious disease diagnostics market in Zambia presents significant opport


Research and Markets: Study an Overview of the Key Companies Involved In the HIV Pipeline, Including an Analysis of the New Corporate Alliances
Business Wire - October 27, 2009
DUBLIN - Research and Markets (http://www.researchandmarkets.com/research/f9e8fd/pipeline_insig ht) has announced the addition of the Pipeline Insight: HIV - The Age of Convenience report to their offering. Three new partnerships are reshaping the competitive environment in HIV. Most notably, Tibotec/


Russia: AIDS Healthcare Foundation to Join Three Respected Saint-Petersburg Partners in Innovative New HIV Testing and ARV Treatment Collaboration
Business Wire - October 27, 2009
Group to Formalize Agreement in Signing Ceremony in Moscow Wednesday, October 28 Partnership of AHF, Saint-Petersburg Government Healthcare Institution s Center for Prevention and Control of Infectious Diseases; AIDS, Statistics, Health, a Regional NGO; and Saint-Petersburg Government Healthcare Institution s Policlini


NanoViricides Management Reports that the Company is Fiscally Sound and Its Drug Development Programs are Progressing Successfully
Business Wire - October 26, 2009
WEST HAVEN, Conn. - NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility. The Company


Mormon Marriott's Moral Masquerade: Hotel Chain Profits off of Unsafe Porn, Says AHF
Business Wire - October 21, 2009
As Part of Ongoing Campaign to Require Condom Use in Adult Films, Advocates from AIDS Healthcare Foundation and Pink Cross Foundation will Protest the Mormon-founded Marriott Hotel Chain as Middlemen Selling Condom-less Porn via Its Entertainment Lineup in the Chain s Hotel Rooms Group to Host Press Conference, Porn In


Congress Enacts AIDS Bill to Test 5 Million; AHF Urges President Obama to Act Swiftly
Business Wire - October 21, 2009
House and Senate Pass Bill Placing Greater Focus on Finding Undiagnosed HIV Positive Individuals; Largest Global AIDS Organization Lauds Congress for Updating Ryan White CARE Act to Prioritize Testing and Maintain a Focus on Medical Care While Cutting Bureaucracy WASHINGTON - AIDS Healthcare Foundation (AHF), the large


Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference
Business Wire - October 21, 2009
Personalized Immunotherapy Candidate Demonstrates: * Viral Load Control in Absence of Antiretroviral Therapy * Robust Immune Response to a Diverse Set of HIV Antigens * Potential to Offer Independence from Antiretroviral Therapy AIDS Vaccine 2009 conference DURHAM, N.C. and PARIS - Argos Therapeutics today announced tw


Thai HIV Vaccine Hype: AHF Reiterates Calls for Independent Review of AIDS Vaccine Effort
Business Wire - October 20, 2009
LOS ANGELES - In anticipation of today s controversial presentation of the Thai HIV vaccine study data at the AIDS Vaccine Conference in Paris, AIDS Healthcare Foundation (AHF) reiterated its disappointment at the news that data that seriously undermined the purported success of the trial were not released publicly whe


Inovio Biomedical and Its Collaborators Present Research and Clinical Data at AIDS Vaccine 2009 Conference
Business Wire - October 20, 2009
Dr. David Weiner Highlights the Strengths of Inovio s SynCon(TM) DNA Vaccines for Diseases Such as HIV and HPV SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio s Scientific Advisory Board, highlig


Bicycles for Humanity Colorado Changes Lives for Rural Africans
Business Wire - October 19, 2009
Provides Much Needed Access to Healthcare, Education and Economic Opportunities DENVER - Imagine having to walk 15 miles to get the medication you need to save your life. That s just what Africans have to do in the rural town of Singalamwe, Namibia where the HIV infection rate has reached 40 percent. Bicycles for Human


American Latino Theatre Teams Up with AIDS Healthcare Foundation to Raise Awareness about HIV/AIDS among High School Students
Business Wire - October 16, 2009
LOS ANGELES - Fresh off the heels of its successful opening of Arthur Meiselman s AIDS drama Hello and ...Goodbye!, the American Latino Theatre (AmLT) announces its partnership with AIDS Healthcare Foundation (AHF). This effort aims to create a stronger connection between the two organizations and targets the Latino co


Texas Orthopaedic Surgeon to Provide Individuals Living with HIV/AIDS Equal Access to Services
Business Wire - October 16, 2009
HHS Office for Civil Rights and Texas Orthopedic Surgeon Sign Settlement Agreement WASHINGTON - An Austin, Texas orthopaedic surgeon has agreed that he and his staff will not deny or withhold medically appropriate treatment from patients solely because they are HIV-positive, according to the U.S. Department of Health a


FHLBank Pittsburgh Awards $3.4 Million in Affordable Housing Grants
Business Wire - October 16, 2009
PITTSBURGH - The Board of Directors of the Federal Home Loan Bank of (FHLBank) has approved $3,446,246 in grants under its Affordable Housing Program (AHP). The grants will help finance 17 housing projects – three in Delaware, eight in Pennsylvania, three in West Virginia and one each in Louisiana, New York and Virgini


Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate
Business Wire - October 16, 2009
The International AIDS Vaccine Initiative and the Ragon Institute Signed Memorandum of Understanding to Collaborate on AIDS Vaccine Research NEW YORK - The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development


Vystar(R) Corporation and Alatech Healthcare, LLC Introduce Envy(TM) Condom
Business Wire - October 15, 2009
Companies Sponsor Atlanta AIDS Walk and Donate 12,000 Condoms to AID Atlanta ATLANTA - Vystar Corporation and Alatech Healthcare, LLC introduce the new Envy(TM) male latex condom made with Vytex(R) Natural Rubber Latex (NRL), an ultralow protein latex material with significantly reduced levels of antigenic proteins tha


Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine under Its "Fillanthropy(TM) Program"
Business Wire - October 15, 2009
ATLANTA - Today, Formatech, Inc. announced that GeoVax Labs, Inc. s (OTC BB: GOVX) ( GeoVax ) ( Company ) HIV/AIDS vaccine will be the first clinical candidate that is formulated and filled under its Fillanthropy Program. The production run is scheduled to be completed in January 2010. Under this program, Formatech wil


Statement by Kathleen Sebelius, Secretary of Health and Human Services, on National Latino AIDS Awareness Day, October 15, 2009
Business Wire - October 15, 2009
WASHINGTON - National Latino AIDS Awareness Day is a reminder of HIV and AIDS heavy impact on the Latino community. Every nine and a half minutes someone new is infected with HIV, and almost one-fifth of people who are living with HIV and AIDS are Latino. The rate of new HIV infections among Hispanic men is more than d


Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation
Business Wire - October 15, 2009
Phase I Trial Will Assess Safety of and Immune Responses to Inovio s PENNVAX(TM)-B Preventive HIV Vaccine SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, and the HIV Vaccine Trials Network (HVTN) announced today the initiation of a phase I clinical s


AHF Opens 'Men's Wellness Center' in North Miami
Business Wire - October 14, 2009
Walk-In Clinic to Provide Confidential Sexual Health Services--Including HIV and STD Testing and Treatment--in One Convenient Location and At No Cost to Clients MIAMI - On Tuesday, October 13th, AIDS Healthcare Foundation (AHF) opened a Men s Wellness Center at AHF Magic Johnson Healthcare Center located at Jackson Nor


Argos Therapeutics to Present Positive Immune Response and Viral Load Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference
Business Wire - October 13, 2009
AIDS Vaccine 2009 Conference DURHAM, N.C. - Argos Therapeutics today announced the presentation of two abstracts at the AIDS Vaccine 2009 conference, being held October 19-22 in Paris, France . Favorable immune response, viral load and safety data from the ongoing Phase 2a proof-of-concept trial of AGS-004 therapy for


Inovio Biomedical CEO Introduces DNA Vaccine Potential at 2009 World Knowledge Forum
Business Wire - October 13, 2009
Dr. J. Joseph Kim Reports Completion of Clinical Product Manufacturing for Its H1N1 Influenza Vaccine SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, president and CEO, presented at the invitation-only World Kno


AHF Lauds Gov. Schwarzenegger for Signing Streamlined Rapid HIV Testing Bill
Business Wire - October 12, 2009
AB 221 (Portantino, D--Pasadena) Eliminates a Requirement that HIV Testing Counselors Using Finger Stick Rapid Tests be Trained as Limited Phlebotomy Technicians, a Costly and Outdated Barrier to Expanding Access to HIV Testing SACRAMENTO, Calif. - AIDS Healthcare Foundation (AHF), the operator of the largest non-gover


Thai HIV Vaccine Hype Misrepresents Data; AHF Calls for Independent Review of AIDS Vaccine Effort
Business Wire - October 12, 2009
LOS ANGELES - AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which now provides treatment and services for more than 110,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, expressed frustration and disappointment at the news th


E-18 Corp. Releases Protectus Management Profile on Jack Dillard, Inventor of the Protectus Safety Syringe
Business Wire - October 09, 2009
Physicist by Training and Prolific Engineer/Inventor, Jack Dillard Represents Protectus Core Technology and Serves as VP of Operations and Chief Operating Officer MINNEAPOLIS - E-18 Corp. (OTCBB:ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ( Protectus


Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug
Business Wire - October 08, 2009
In Light of Today s FDA Advisory Committee Approval--and Likely Market Expansion for Selzentry--AHF Urges Drug Giant to Lower Price Immediately Current Selzentry Cost: Average Wholesale Price of $13,767 per-patient per-year LOS ANGELES - Responding to today s news that the Food and Drug Administration (FDA) Antiviral A


WHO Reports 4M Poor People on AIDS Treatment; AHF Hails Accomplishment, But Notes Millions More Still Lack Access to Lifesaving Treatment, HIV Testing
Business Wire - October 08, 2009
Joint WHO, UNAIDS and UNICEF Report of 4M People from Low and Middle Income Countries on Treatment in 2008 is a 36% Increase from 2007; However, Millions of the 33M People Infected Worldwide Still Lack Treatment--and Many Don t Even Know They Are HIV-Positive LOS ANGELES - AIDS Healthcare Foundation (AHF) today hailed


FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Business Wire - October 08, 2009
NEW YORK - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration s ( FDA ) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry(R) (maraviroc) tablets for use in treatment-naive adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.


CytoDyn Transfers Research on Novel AIDS Drug to Massachusetts General Hospital
Business Wire - October 08, 2009
SANTA FE, N.M. - In response to new economic and regulatory realities, CytoDyn, Inc. (Pink Sheets:CYDY) has made a sea change in its strategy for developing Cytolin(R), the Company s unique immune therapy for treating HIV/AIDS. Studies of the drug will be designed and conducted by Massachusetts General Hospital, one of


Video Business Announces 2009 Video Hall of Fame Inductees
Business Wire - October 08, 2009
LOS ANGELES - Leading home entertainment news magazine Video Business (www.VideoBusiness.com) announces the induction of retailer Best Buy, Summit Home Entertainment President Stephen Nickerson and Microsoft Corporate VP, Media and Entertainment Group, Blair Westlake into the 2009 Video Hall of Fame. The inductees will


Actors Jaden and Willow Smith Join Hasbro, Inc.'s PROJECT ZAMBI as Youth Ambassadors
Business Wire - October 07, 2009
Young Stars Lend a Hand for the PROJECT ZAMBI Celebrity Charity Auction PAWTUCKET, R.I. - Actors and brother and sister duo Jaden and Willow Smith are joining Hasbro, Inc. s (NYSE:HAS) PROJECT ZAMBI as the program s Youth Ambassadors to help raise awareness for the estimated 15 million children who have lost parents an


FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR
Business Wire - October 06, 2009
WASHINGTON - The U.S. Department of Health and Human Services (HHS) today marked today marked the recent approval of the 100th antiretroviral drug in association with the President s Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS wo


Vodafone Americas Foundation Announces Launch of Second Annual Wireless Innovation Project
Business Wire - October 05, 2009
$600,000 To Be Awarded to Projects Demonstrating Promise of Solving Critical Global Issues WALNUT CREEK, Calif. - The Vodafone Americas Foundation(TM) is pleased to announce the launch of the second annual Vodafone Wireless Innovation Project, a competition to identify and reward the most promising advances in wireless


Advanced Liquid Logic Receives $5.2 Million NIH Contract for HIV Diagnostics
Business Wire - October 02, 2009
RESEARCH TRIANGLE PARK, N.C. - Advanced Liquid Logic announced today that it has received a large, four-year contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for the development of a rapid, point-of-care, diagnostic device for the detection of HIV in lo


Avexa Closes ATC's Phase III Trial to Evaluate Data
Business Wire - October 01, 2009
MELBOURNE - Avexa Limited (ASX:AVX) today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results


San Francisco, Sept. 30th: Grand Opening of New AHF "Magic Johnson" HIV/AIDS Clinic on Church St.
Business Wire - September 30, 2009
Event Marks the Opening of AHF s First All-in-One Site--and the First of its Kind in the Nation--With a Healthcare Center, AHF Pharmacy, Out of the Closet Thrift Store and Free HIV Testing All in One Location SAN FRANCISCO - AIDS Healthcare Foundation (AHF), the US largest non-profit HIV/AIDS healthcare provider, which


Quintiles Launches Clinicalresearch.com
Business Wire - September 30, 2009
An Easy-to-Use Web Site Designed to Drive Awareness, Understanding and Participation in Clinical Research around the World RESEARCH TRIANGLE PARK, N.C. - Patients who want to play an active role in bringing new, safer drugs to market faster now have access to a global Web site that makes it easier than ever before to i


SeraCare Life Sciences Awarded Multiple Contracts from the CDC and NIH to Support HIV Research and the Accuracy of HIV Testing
Business Wire - September 29, 2009
-Total US Government funded dollars awarded to SeraCare exceeds $35 million over the past two years - MILFORD, Mass. - SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) an


ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections
Business Wire - September 29, 2009
LUXEMBOURG & MELBOURNE, Australia - ABL, S.A. and Evivar Medical Pty Ltd today announced the completion of agreements to cross-licence their respective intellectual property portfolios and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis (namely The


Mondial Assistance Joins Global Partnership for Humanitarian Aid
Business Wire - September 28, 2009
MASSIVEGOOD Encourages Travellers to Support World Health Initiatives RICHMOND, Va. - Mondial Assistance today announced its participation in a new global fundraising initiative, aptly named: MASSIVEGOOD. The aim of MASSIVEGOOD is to encourage consumers to make small, voluntary financial contributions (around $2, for


PEPFAR, USAID and General Mills Partner to Improve Food Processing in Africa
Business Wire - September 28, 2009
Partnership Underscores U.S. Government Initiatives to Address Global Health and Hunger MINNEAPOLIS - On Friday, September 25, 2009, Secretary of State Hillary Rodham Clinton announced a public-private partnership with General Mills, a leading U.S. food company, the U.S. Agency for International Development (USAID) and


San Francisco, Sept. 30th: Grand Opening of New AHF "Magic Johnson" HIV/AIDS Clinic on Church St.
Business Wire - September 28, 2009
Event Marks the Opening of AHF s First All-in-One Site--and the First of its Kind in the Nation--With a Healthcare Center, AHF Pharmacy, Out of the Closet Thrift Store and Free HIV Testing All in One Location SAN FRANCISCO - AIDS Healthcare Foundation (AHF), the US largest non-profit HIV/AIDS healthcare provider, which


IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand
Business Wire - September 24, 2009
NEW YORK - The International AIDS Vaccine Initiative (IAVI) greeted with excitement today s announcement by the U.S. Military HIV Research Program and the Thai Ministry of Public Health that, according to an initial analysis, a prime-boost combination of two AIDS vaccine candidates has shown partial efficacy in a phase


Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV
Business Wire - September 24, 2009
SOUTH SAN FRANCISCO, Calif. - Global Solutions for Infectious Diseases ( GSID ) announced today that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The double-blind, placebo controlled study was conducted in


Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities
Business Wire - September 23, 2009
Affects Cambridge, Boston, Framingham, Cape Cod, Lowell, Springfield, Northampton, Worcester, and Hampshire County BOSTON - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the ba


Academy of Friends Selects Eleven Bay Area HIV/AIDS Organizations as 2010 Gala Beneficiaries
Business Wire - September 22, 2009
Celebrates 30 Years of Raising Awareness, Donating Funds, and Encouraging Volunteerism for HIV/AIDS Agencies Throughout the Bay Area SAN FRANCISCO - Academy of Friends proudly announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations. Known for its annual Academy Awards(R) Night Charity Gala an


Flowers Heritage Foundation Honors Miami-Based Physicians for Commitment to Public Health
Business Wire - September 22, 2009
Award Recipients Recognized at Leadership Symposium for Test Miami Initiative OAKLAND, Calif. & MIAMI - The Flowers Heritage Foundation, a nonprofit organization dedicated to identifying gaps in healthcare services and systems and treating health disparities with effective public health solutions, announced it has


ARISE Magazine is Proud to Announce Sponsorship Commitment to Alicia Keys' 2009 Keep a Child Alive Black Ball
Business Wire - September 22, 2009
NEW YORK - Keep a Child Alive s (KCA) 2009 Black Ball, an annual benefit to raise funds dedicated to providing life-saving treatment and support to children and families affected by HIV/AIDS, is proud to announce ARISE Magazine as a confirmed sponsor. ARISE Magazine, the first global magazine dedicated to highlighting


Susan G. Komen for the Cure(R) Founder Nancy G. Brinker Warns of Coming Global Cancer Crisis; Calls on World Leaders at United Nations to "Include Cancer" on Health Agendas
Business Wire - September 22, 2009
Komen Launches Petition Drive on www.includecancer.org; Urges Leaders to Meet Goals for Maternal Health and Empowering Women NEW YORK - The leader of the global breast cancer movement today warned of a coming wave of cancer deaths and told global health ministers to be fearless and united in addressing the growing canc


AIDS Healthcare Foundation's First 'AHF Blair Underwood Healthcare Center' to Open in DC
Business Wire - September 21, 2009
Actor, AIDS Advocate and Clinic Namesake Blair Underwood to Cut Ribbon at September 24th Grand Opening Ceremony in Washington, Where HIV Rate Now Surpasses Lagos, Nigeria WASHINGTON - AIDS Healthcare Foundation (AHF), the US largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to


NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies
Business Wire - September 21, 2009
WEST HAVEN, Conn. - NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), reported today that it has signed a Master Service Agreement with the Southern Research Institute ( Southern Research ), Birmingham, AL. Southern Research is a well established, prestigious institution that has performed preclinical testing servi


Zacks Analyst Blog Highlights: Merck, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Abbott Labs
Business Wire - September 18, 2009
http://www.profit.zacks.com/ CHICAGO - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Merck (NYSE: MRK), Bristol-Myers


MyInsuranceExpert Supports Local Aids Walk in Effort to Increase Healthy Living Awareness
Business Wire - September 18, 2009
TROY, Mich. - My Insurance Expert, one of the nation leading online services to compare and secure affordable health insurance, is supporting AIDS Walk Detroit 2009 with a corporate donation and encouraging employees and friends to participate in the annual fund-raiser. HIV and AIDS are devastating diseases, says Lorne


The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine
Business Wire - September 18, 2009
Media Briefing will present recent significant progress and symposium highlights; interview opportunities; lab tour - MEDIA ADVISORY: WHAT: International Symposium Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV. More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent s


BioAlliance Pharma Makes Four Presentations at the 49th ICAAC Meeting Including Three Phase III Study Results with miconazole Lauriad(R) and One with Its Integrase Inhibitor
Business Wire - September 15, 2009
PARIS - Regulatory News: BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad(R) and anti-integrase inhibitor. The results of a phase III study with miconazole Lauriad(R) mucoadhesive buccal tab


HP and NBA Launch Digital Assist Competition
Business Wire - September 15, 2009
NBA All-Star Antawn Jamison to Help Tip Off Education Grant Competition Providing Underserved Public Schools a Chance to Win More Than $450,000 in HP Technology WASHINGTON - HP (NYSE:HPQ) and the National Basketball Association today tipped off the HP Digital Assist education grant competition. HP and NBA executives we


European Union Commission Approves Expanded Use of ISENTRESS(R) (raltegravir), from MSD, in Adult Patients with HIV-1 Infection
Business Wire - September 15, 2009
WHITEHOUSE STATION, N.J. - Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS(R) (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult pa


Cytheris Announces Interim Data from INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIV-Infected Patients
Business Wire - September 15, 2009
Phase I/IIa Data at Week 12 Show More Patients Experienced CD4 Counts > 500 Cells/mm3 When Treated at 20mcg/Kg Dose Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)


NanoViricides Platform Enables Rapid Development of Robust Nanomedicines Against Influenza and HIV
Business Wire - September 14, 2009
Company President Dr. Diwan Describes Technology and Pipeline at NanoBusiness 2009 Conference NanoBusiness 2009 WEST HAVEN, Conn. - NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), announced today that Anil Diwan, PhD, President of the Company presented a talk at NanoBusiness 2009 - the 8th annual NanoBusiness Con


Merck's ISENTRESS(R) (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naive Patients
Business Wire - September 13, 2009
SAN FRANCISCO - ISENTRESS(R) , an integrase inhibitor from Merck & Co. , Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naive) HIV-1-infected patients through 96 we


E-18 Corp. Announces Update to SmallcapInsights.com Article
Business Wire - September 11, 2009
Industry Veteran, Dr. John Faessel, Provides Additional Commentary on Protectus Safety Syringe and Explains Benefits of Company s Recent International Patent-Pending Status MINNEAPOLIS - E-18 Corp. (OTCBB:ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices (


CA Legislature Passes Streamlined Rapid HIV Testing Bill; AHF Urges Schwarzenegger to Sign Common Sense Law
Business Wire - September 11, 2009
AB 221 (Portantino, D—Pasadena) Eliminates a Requirement that HIV Testing Counselors Using Finger Stick Rapid Tests be Trained as Limited Phlebotomy Technicians, a Costly and Outdated Barrier to Expanding Access to HIV Testing SACRAMENTO, Calif. - AIDS Healthcare Foundation (AHF), the operator of the largest non-govern


Dynavax Reports FDA Removes Clinical Hold on HEPLISAVTM Phase 3 Hepatitis B Vaccine
Business Wire - September 10, 2009
BERKELEY, Calif. - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced that the U.S. Food and Drug Administration ( FDA ) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease. HEPLISAV is a Phase 3 investigational adult hepatit


Quintiles Announces Clinical Research Partnership with the University of Pretoria
Business Wire - September 10, 2009
Quintiles Prime Site Program Expands into South Africa to Accelerate Clinical Development RESEARCH TRIANGLE PARK, N.C. - Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with


Warner Bros. Consumer Products Announces Highly Anticipated Online Auction for World-Renowned Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection in Celebration of the 70th Anniversary of The Wizard of Oz
Business Wire - September 10, 2009
Charity Auction Opens Today, September 10, at www.RubySlipperAuction.com Auction to Close on September 24 at Warner Bros. Entertainment s Star-Studded Emerald Gala in New York City BURBANK, Calif. - Warner Bros. Consumer Products today announced the opening of the highly anticipated online auction for The Ruby Slipper


E-18 Corp. Announces Availability of a White Paper by SmallcapInsights.com
Business Wire - September 10, 2009
Paper Delves into Background of Dangerous Needlestick Injuries and Discusses Growing Opportunities in the Safety Syringe Market MINNEAPOLIS - E-18 Corp. (OTCBB:ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ( Protectus Medical Devices ), today announces


HIV Screening Tests Proposed to Be Added to Medicare's List of Covered Preventive Services
Business Wire - September 09, 2009
WASHINGTON - The Department of Health and Human Services (HHS) today announced a new proposal that would cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are pregnant and Medicare beneficiaries of any age who volunta


Over One Third of All Oral and Throat Cancers Are Due to Sexual Practices
Business Wire - September 09, 2009
BEVERLY HILLS, Calif. - Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower Cancer Research Foundation. Dr. Hamburg explained, In the past, o


Cytheris to Present Interim Data from INSPIRE HIV Multicenter Study in Oral Late Breaker at ICAAC
Business Wire - September 09, 2009
49th Interscience Conference on Antimicrobial Agents and Chemotherapy PARIS - Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients w


Complete Genomics Demonstrates Its Technology's Potential by Sequencing 14 Human Genomes for Customers
Business Wire - September 09, 2009
Its High-Quality, Low-Cost Human Genome Sequencing Technology is Helping to Further Cancer, Metabolic and Neurologic Disease Research MOUNTAIN VIEW, Calif. - Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to cust


St. Vincent's, State Health Department Unveil Novel Technology to Fight Spread of HIV
Business Wire - September 09, 2009
Unique Widget Gives Doctors, Nurses Timely, Accurate Information NEW YORK - Saint Vincent Catholic Medical Centers and the New York State Department of Health (DOH) today unveiled a novel Web-based technology to rapidly instruct health care providers throughout New York State about HIV diagnosis and prevention. Deve


FDA and BioTrove Collaborate to Evaluate BioTrove's Novel Genetic Profiling and Pathogen Detection System for Possible Use in Detecting Threats to the Nation's Blood Supply
Business Wire - September 08, 2009
CBER/FDA s Division of Emerging and Transfusion Transmitted Diseases to Evaluate the OpenArray PCR-Based SNAP System for Screening the Blood Supply for Viruses, Bacteria and Parasites WOBURN, Mass. - BioTrove announced a collaboration with the U.S. Food and Drug Administration s Center for Biologics Evaluation and Rese


Entertainment's Biggest Names Support Hasbro, Inc.'s PROJECT ZAMBI Through Global Charity Auction
Business Wire - September 08, 2009
George Clooney, Leonardo DiCaprio, Alicia Keys and Taylor Swift Among Those Involved in Hasbro-led Initiative to Provide Support for Children Orphaned by AIDS in Africa PAWTUCKET, R.I. - Celebrities from the worlds of film, television, music and sports have come together to lend a hand for Hasbro, Inc. s (NYSE:HAS) PRO


The Coca-Cola Company Takes High-Tech Approach to Community Funding
Business Wire - September 08, 2009
Internet Simplifies the Application Process ATLANTA - Requesting a charitable grant or community sponsorship from The Coca-Cola Company just got a little easier. Global Community Connections (GCC), the community engagement arm of The Coca-Cola Company, launched a paperless online application system today that will make


AHF Challenges Merck's "Criminal AIDS Drug Pricing" for Isentress
Business Wire - September 03, 2009
Mailer Sent to Residents of Whitehouse Station, New Jersey--Merck s Hometown--Features Mock Wanted Poster with Image of Merck CEO Richard T. Clark; Campaign Seeks to Educate the Public Regarding the High Price of AIDS Drug, Isentress After Recent FDA Approval for Use as First-Line AIDS Treatment, Isentress Now the Most


Aetna Specialty Pharmacy Achieves 95 Percent Average Medication Adherence for Eight Conditions
Business Wire - September 03, 2009
Highly-Trained, Compassionate Staff Providing High-Touch Member Support May Be Key to Higher Adherence Rates over Retail Pharmacy HARTFORD, Conn. - Aetna (NYSE: AET) announced today results of an analysis from the first half of 2009, demonstrating an average medication adherence of over 95 percent (1) for its members t


IAVI: Two New Antibodies Found to Cripple HIV
Business Wire - September 3, 2009
Findings Reveal an Achilles Heel on the Virus for AIDS Vaccine Researchers to Exploit NEW YORK & LA JOLLA & SAN FRANCISCO, Calif. & SEATTLE - Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone


AHF: Pfizer Wrongdoing Echoes Viagra Case
Business Wire - September 02, 2009
A Long-time Advocate Against Unlawful and Irresponsible Drug Marketing Tactics, AHF Lauds the U.S. Justice Department for Holding Pfizer Accountable WASHINGTON - As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today lauded the U.S. Justice Department s crackdow


E-18 Corp. Announces Availability of SmallcapInsights.com Article
Business Wire - September 01, 2009
Industry Veteran, Dr. John Faessel, Discusses Enormous Opportunity for the Protectus Safety Syringe and Provides His Unique Perspective as a Healthcare Professional MINNEAPOLIS - E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ( Protect


Zacks Analyst Blog Highlights: Mylan, Sanofi-Aventis, Gilead Sciences, GlaxoSmithKline and Freddie Mac
Business Wire - August 31, 2009
http://www.profit.zacks.com/ CHICAGO - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mylan (Nasdaq: MYL), Sanofi-Aventis (NYSE:


Mexico: AHF's "LOVE Condoms" Campaign Kicks Off in Five Cities
Business Wire - August 31, 2009
AHF Hosted Launch Events in Mexico City, Cancun, Manzanillo, Monclova and Tijuana on Friday, Part of its Worldwide Advocacy Campaign to Scale-Up Global Condom Distribution and HIV Testing Efforts MEXICO CITY - AIDS Healthcare Foundation (AHF), has successfully launched its popular Love Condoms campaign in Mexico with f


WTN Services(R) and the Winetasting Network(R) Take Lead in Philanthropic Effort
Business Wire - August 27, 2009
NAPA, Calif. - WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community. WTN Services(R) and the Winetasting Network(R) have again announced they are lead corp


Ethical Currency: First Ethical Foreign Exchange Broker Launched
Business Wire - August 27, 2009
* Ethical Currency donates 0.005% of transactions to charity * Company campaigning for currency transaction levy LONDON - The world s first foreign exchange broker to donate part of its turnover to charity launched today. City-based Ethical Currency has committed 0.005% of all transactions to the Global Fund, set up to


Xhale Awarded NIH / NIMH SBIR (Small Business Innovation Research) Phase II Grant for a Breath-Based Medication Adherence System
Business Wire - August 27, 2009
GAINESVILLE, Fla. - Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therap


BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad(R)
Business Wire - August 26, 2009
PARIS - Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad(R) Immunocompetent Patients Study ). This multicenter randomized, double


AIDS Healthcare Foundation Mourns Kennedy as "Champion of People without a Voice"
Business Wire - August 26, 2009
WASHINGTON -- AIDS Healthcare Foundation (AHF), the nation s largest non-profit HIV/AIDS healthcare provider which now provides treatment and services for more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today mourned the passing of Senator Ted Kennedy (D, MA)


AHF: L.A. County Says Impact of Thousands of Infections in Porn Industry, "Minimal"
Business Wire - August 25, 2009
In Eye-popping Legal Demurrer, LA County Lawyers Stupid Enough to Show Complete Disdain for Well-being of Young People Appearing in Porn as Well as Disregard for Health of the Public-at-Large LOS ANGELES - AIDS Healthcare Foundation: In its petition, AHF is requesting that the County take action within the adult film i


HHS Secretary Sebelius Announces Intent to Appoint Dr. Helene Gayle as Chair of the Presidential Advisory Council on HIV/AIDS at 2009 National HIV Prevention Conference
Business Wire - August 24, 2009
WASHINGTON -- Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the 2009 National HIV Prevention Conference. HIV remains a ma


'You Can Never Be Too Careful in Sex and in Journalism' Says Vivid Chief Steven Hirsch
Business Wire - August 24, 2009
LOS ANGELES -- Vivid Entertainment co-chairman Steven Hirsch said today that he was relieved that the Associated Press had distributed a correction to an erroneous story that falsely reported on the leading adult studio s health safety record. The Associated Press is one of the most highly regarded news gathering organ


AHF to File Cal/OSHA Complaints Over Porn Industry's Blacklist on Condoms
Business Wire - August 20, 2009
Group to Submit Nearly 60 Adult Films from 16 California Production Companies Filmed without Condoms that Demonstrate Unprotected Exchange of Bodily Fluids; Several Former Porn Actresses from Pink Cross Foundation to Join AHF s Call for Condoms in Porn


BioAlliance Pharma: FDA Accepts Drug Application for Miconazole Lauriad(R) (Loramyc(R)) to Treat Oropharyngeal Candidiasis
Business Wire - August 19, 2009
PARIS - Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration ( FDA ) has accepted the new drug application (NDA) for miconazole Lauriad(R) (Loramyc(R)) Mucoadhesive Buccal Tabl


Dianne Stewart, Formerly of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Joins IAVI as Vice President of Resource Development
Business Wire - August 19, 2009
NEW YORK - Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development. In her role at IAVI, Ms. Stewart will provide leadership for the organization s fundraisi


Trimeris Reports Financial Results for the Second Quarter 2009
Business Wire - August 13, 2009
DURHAM, N.C. - Trimeris, Inc. (NASDAQ:TRMS) today announced financial results for the quarter ended June 30, 2009, reporting net income of $1.3 million, or $0.06 per share compared with $590,000, or $0.03 per share for the quarter ended June 30, 2008. This result was primarily driven by decreased operating expenses off


Thermo Fisher Scientific Establishes RNAi Discovery Grant Program to Advance Gene Research
Business Wire - August 13, 2009
Five Research Projects to Receive Total of More Than $400,000 in RNAi Screening Tools WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has established a grant program to award life science researchers more than $400,000 in RNA-interference (RNAi) r


Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for the Oral Delivery of Cobra Venom for the Treatment of Pain
Business Wire - August 13, 2009
In Preparation for Entering the Analgesic Market, ReceptoPharm Has Filed a Patent Application for a New Oral Formulation of Cobra Venom and a New Method for Oral Delivery of Cobra Venom Aimed at Treating Pain. BOCA RATON, Fla. - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for


Media Advisory: ELCA Presiding Bishop News Conference August 17
Business Wire - August 12, 2009
WHAT: News Conference with Presiding Bishop Mark S. Hanson, Evangelical Lutheran Church in America (ELCA) WHEN: Monday, Aug. 17, 1:30 p.m. Central Time WHERE: Room 103F, Minneapolis (Minn.) Convention Center PURPOSE: Presiding Bishop Hanson will provide an overview and respond to questions about the 2009 ELCA Churchwid


RetroVirox Receives Second NIH Grant to Develop Novel Antivirals
Business Wire - August 11, 2009
SAN DIEGO - RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVi


AHF to Launch U.S. LOVE Condoms Campaign at "House of Blues Sunset Strip"
Business Wire - August 11, 2009
Ten Los Angeles-Area Nightclubs -- Including MJ s, FuBar, Silverlake Lounge and Gold Coast -- Have Already Installed LOVE Condoms Dispensers, Stocked with Free LOVE -Branded Condoms in Eye-Catching, Red Foil Packets More Than 80,000 Free Condoms Have Been Distributed by AHF in the U.S. and Canada Through


AmeriChoice Launches National Support Initiative for Community Health Centers
Business Wire - August 10, 2009
Grants will go to Community Health Centers nationally Theme of the week is Celebrating America s Health Centers: Where ACCESS and QUALITY CARE Begin MINNEAPOLIS - AmeriChoice Health Plans are sponsoring activities in 20 states to support and recognize their partnerships with Community Health Centers (CHCs). Targeted mi


NanoViricides, Inc. Anti-Herpes Drug Candidate Reduces Viral Load by 99.99%
Business Wire - August 10, 2009
WEST HAVEN, Conn. - NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), announced today that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides(TM) drug candidates. The studies were performed by Thevac in Baton Rouge, LA, in collaboration with the Division of Biote


Chevron and USAID Pledge New Support for Better Outcomes in Angola
Business Wire - August 10, 2009
Agreement Latest in Company s Multimillion Dollar Initiatives in Angola SAN RAMON, Calif. - Chevron Corporation (NYSE:CVX), the United States Agency for International Development (USAID) and the Cooperative League of the United States of America (CLUSA) today announced the basis for a new partnership aimed at supportin


Schwarzenegger's 'Catastrophic' AIDS Funding Cuts to be Protested at Pershing Square Vigil & March Tuesday Aug 11th
Business Wire - August 07, 2009
Slash and Burn Approach is Wrong-headed Way for State to Handle Public Health Epidemic LOS ANGELES - AIDS Healthcare Foundation (AHF), the nation s largest non-profit HIV/AIDS healthcare provider, is joining a broad-based coalition of AIDS advocates and patients to protest draconian budget cuts that were blue lined ou


One Teen's Wish Creates Zara's Center Dedicated to Helping AIDS Orphans in Zimbabwe
Business Wire - August 07, 2009
Rachael Plutzik s Dream Leads to Sustainable Support from New York City Marathon Runners NEW YORK - Rachael Plutzik seems like an ordinary teenager and student growing up in New York City. She likes hanging out with her friends and family, singing in her a cappella group, playing the guitar, and reading Harry Potter bo


TB Alliance Appoints Head of External Affairs
Business Wire - August 06, 2009
Veteran Executive Marshall Burke to Guide Organization s Resource Mobilization, Advocacy, and Policy Efforts NEW YORK - The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of new drugs to fight tuberculosis (TB), today an


President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries
Business Wire - August 06, 2009
Pfizer commits to improve access through a 60 percent price decrease to $1 per dose on drug to treat TB in patients taking second-line HIV/AIDS medications. Once-daily four-drug combination for second-line treatment of HIV/AIDS available from Matrix, a Mylan company, at $475 annually today and at $425 annually in 201


AHF/Uganda Care's Stay Negative/Love Condoms Campaign Kicks Off in Uganda
Business Wire - August 05, 2009
AHF s Uganda Cares to host a Launch Event on Thursday, August 6th at Pan-African Freedom Square in Kampala Group to Provide Free HIV Testing as Part of Uganda s LOVE Condoms Campaign Kickoff KAMPALA, Uganda - AIDS Healthcare Foundation (AHF) is proud to announce the launch of its popular STAY NEGATIVE and Love Condo


Dr. Nathaniel Brown Joins Presidio Pharmaceuticals, Inc. as Senior Vice President of Clinical Development
Business Wire - August 05, 2009
SAN FRANCISCO - Presidio Pharmaceuticals, Inc. is pleased to announce that Dr. Nathaniel Brown has joined the Company as Senior Vice President of Clinical Development. Nat has had a stellar career and brings to the Company a wealth of experience and expertise in the clinical development of small molecule therapeutics f


Napo Pharmaceuticals Completes Dose Selection Phase of ADVENT Trial: Final Stage to Begin in Adaptive Study of Treatment for Chronic Diarrhea in People living with HIV/AIDS
Business Wire - August 04, 2009
SOUTH SAN FRANCISCO, Calif. - Napo Pharmaceuticals, Inc. is pleased to announce the completion of the dose selection stage (Stage I) of the ADVENT trial of crofelemer for the treatment of chronic diarrhea in people living with HIV/AIDS on antiretroviral therapies. Up to 30 percent of the one million people living with


Dynavax Announces Path for HEPLISAVTM Hepatitis B Vaccine Development
Business Wire - August 04, 2009
BERKELEY, Calif. - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced it has met with the U.S. Food and Drug Administration ( FDA ) to discuss its plans to resume development of HEPLISAVTM, the Company s Phase 3 investigational hepatitis B vaccine. Dynavax proposed the continued clinical development of HEPL


Micronics Receives NIH SBIR Phase 2 Grant to Advance Rapid Molecular Test for HIV Diagnosis
Business Wire - August 03, 2009
Development effort focuses on mother-to-child disease transmission REDMOND, Wash. - Micronics, Inc., today announced that it has been awarded a phase 2, two-year Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) tot


Dicerna Pharmaceuticals Scientific Founder to Present Data Demonstrating Dual Inhibitory Function of Aptamer-Dicer Substrate siRNA Conjugates at Oligonucleotide Therapeutics Conference
Business Wire - August 03, 2009
Data Supportive of Dicerna s Collaboration with Archemix to Combine the Companies Proprietary Delivery and Gene Silencing Technologies for Optimal Therapeutic Benefit Drug Discovery Technology 2009 WATERTOWN, Mass. - Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel the


Intel Helps Convert Unused PC Processor Power Into an Instrument to Fight Disease and Study Climate Change
Business Wire - August 03, 2009
New Application Combines Social Networking Power of Facebook With the Life-Changing Promise of Volunteer Computing SANTA CLARA, Calif. - Often in the fight against cancer, researchers are not limited by their ingenuity, but the resources available to make research effective. The processor power needed to handle complex


Sales of (STARBUCKS)RED Products Generate Funds to Help Communities Where Farmers Live
Business Wire - July 31, 2009
SEATTLE - Starbucks Coffee Company (NASDAQ: SBUX): WHAT: Less than a year after Starbucks Coffee Company (NASDAQ: SBUX) announced a multi-year partnership with (RED)(TM), the company is proud to announce that contributions from millions of daily purchases of (STARBUCKS)RED products have generated contributions equal to


UMLAZI: AHF to Launch Popular 'LOVE Condoms' Campaign Worldwide
Business Wire - July 30, 2009
US Largest AIDS Group Partners with Respected Local Groups in Africa, Latin America and the Asia Pacific Region in Ambitious Free Condom Distribution Campaign and Increased HIV Testing Efforts In South Africa , AHF s Ithembalabantu Clinic Will Host a Launch Event on Saturday, August 1st, at Mega City, Providing Free HI


Allion Healthcare Announces New Partnership with Being Alive San Diego
Business Wire - July 30, 2009
Partnership Will Allow Allion Healthcare Access to over 6,000 Being Alive San Diego Clients in San Diego County MELVILLE, N.Y. - Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it has entered into a partnership with Being Alive San Diego to launch a Community Learning Center in San Diego, California. The b


First Class of Global Health Corps Trains at Stanford for Work in Africa, United States
Business Wire - July 29, 2009
STANFORD, Calif. - Isaac Mutabizi was born and raised in a refugee camp in Uganda and did not see his native country of Rwanda until he was 16 years old, returning for the first time with millions of his countrymen following the 1994 genocide. Now, he is working in Rwanda to help rebuild the country s health-care syste


"Where's Nancy?"; Pelosi Silent While CA Health Care Crumbles
Business Wire - July 29, 2009
Gov. Schwarzenegger s $243 Million Cuts in Health and Human Services Goes Unnoticed by California Congressional Delegation Speaker Leads Health Care Reform in the House, While the Children, Poor, Elderly and Ill of Her Own State Lose Their Health Care Safety Net WASHINGTON - AIDS Healthcare Foundation (AHF), the US la


Global Relief Agency Planet Aid Boosts Efficiency With CipherLab Mobile Computers
Business Wire - July 29, 2009
CipherLab 8000 series helps automate clothing collection and recycling in 19 states PLANO, Texas - CipherLab (www.cipherlab.com), a leading innovator in Automated Identification and Data Capture (AIDC) for the retail, warehouse and distribution markets, today announced that international relief agency Planet Aid (www.p


Governor "Terminator" Kills AIDS Program
Business Wire - July 28, 2009
In a Heartless Act Governor Schwarzenegger Dismantles California s Lifesaving HIV/AIDS Prevention, Testing, Housing and Treatment Services Deadly Cuts Will Cripple HIV Testing & Prevention Efforts, Endanger Public Health and Cost California Taxpayers Infinitely More in the Future LOS ANGELES - AIDS Healthcare Found


Pall Life Sciences Medical Director Receives Medal of Honor
Business Wire - July 28, 2009
EAST HILLS, N.Y. - Pall Corporation (NYSE: PLL) announced today that Joseph Steven Cervia, M.D., senior vice president and global medical director for Pall Life Sciences, has received the 2009 Alumni Medal of Honor from the Board of Governors of New York Medical College. The award was bestowed in recognition of Dr. Cer


AHF Renews Challenge to Merck on Price of AIDS Drug Isentress
Business Wire - July 24, 2009
AIDS Drug Initially Approved as a Salvage Therapy Gets FDA Nod for Use as First Line HIV Treatment, Which Vastly Expands Company s US Market; Isentress Now the Most Expensive First Line Therapy WASHINGTON - AIDS Healthcare Foundation (AHF) today renewed its challenge to Merck and Co. Pharmaceuticals, over the steep pri


CHMP Recommends Expanded Use of ISENTRESS(R) (raltegravir), from MSD, in Adult Patients with HIV-1 Infection
Business Wire - July 24, 2009
WHITEHOUSE STATION, N.J., U.S.A. - Merck, Sharp & Dohme (MSD) today received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending expanded marketing authorisation for ISENTRESS(R) (raltegravir) in combination with other antiretroviral (ARV) medicinal products for the treatm


International Health Leaders Join Forces to Boost Routine HIV Screening and Improve Care in Public Health Settings
Business Wire - July 23, 2009
Event Brings Together Health Officials and Advocates from U.S. and South Africa CAPE TOWN, South Africa & OAKLAND, Calif. - International health leaders, medical professionals, researchers and public health advocates from the United States and South Africa will gather in Cape Town today for Towards Global Routiniz


AHF Receives Generous Grant from S.L. Gimbel Foundation Fund
Business Wire - July 23, 2009
$10,000 Grant Will Fund AIDS Healthcare Foundation s Educational Support Group Program Designed to Improve Health Outcomes for Those Living with HIV/AIDS LOS ANGELES - AIDS Healthcare Foundation (AHF) is pleased to announce that it has received a generous grant in the amount of $10,000 from the S.L. Gimbel Foundation F


Trimeris Reports Second Quarter 2009 FUZEON(R) Sales Results
Business Wire - July 22, 2009
* FUZEON Sales increase 5% over the first quarter of 2009 DURHAM, N.C. - Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the second quarter of 2009 were $29.1 million, down 24 percent from $38.3 million in the second quarter of 2008, and up 5 percent from $27.8 million in the first quart


Profectus Biosciences Secures $5M in Series C Venture Funding: Additional $1M Equipment Leasing Line of Credit for Vaccine Innovation Center
Business Wire - July 22, 2009
BALTIMORE & TARRYTOWN, N.Y. - Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, announced today that the company has closed on a $5 million Series C venture financing round. Current investor Cross


CytoDyn Completes Safety Testing of Cytolin(R): Benchmark for Improved Treatment of HIV/AIDS
Business Wire - July 22, 2009
SANTA FE, N.M. - CytoDyn, Inc. (Pink Sheets:CYDY) has completed safety testing of its current inventory of Cytolin(R), the Company s immune-system modulator for managing HIV disease and the public health crisis afflicting communities where the infection is spreading due to unprotected sex and the other risk factors for


Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring
Business Wire - July 21, 2009
-- DART Study Investigators Present Favorable Viread Safety Results at IAS Conference -- IAS Conference CAPE TOWN, South Africa - Gilead Sciences , Inc. (Nasdaq:GILD) today highlighted results from a study known as DART (Development of Anti-Retroviral Treatment in Africa), w


96-Week MERIT ES Analysis Shows Efficacy Of Pfizer's HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naive HIV Patients; Results Consistent With 48-Week Analysis
Business Wire - July 21, 2009
NEW YORK - At 96-week follow up, data from the MERIT ES analysis show that treatment-naive HIV patients taking Celsentri/Selzentry (maraviroc), in combination with Combivir (R) (zidovudine/lamivudine) experienced comparable virologic suppression to undetectable levels and significantly greater increases in CD4 T-cell c


Bristol-Myers Squibb's SECURE THE FUTURE Announces $1.3 Million in New Grants to Enhance Community-Based HIV/AIDS Care and Support in Africa
Business Wire - July 20, 2009
Ten Years Since Launch, SECURE THE FUTURE Continues to Help Shape the Response to the HIV/AIDS Pandemic CAPE TOWN, South Africa - Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb Foundation today announced new grants providing technical assistance and $1.3 million in funding to community-based orga


ISENTRESS(R) (raltegravir), from MSD, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naive Patients up to 144 Weeks When Used in Combination Therapy
Business Wire - July 20, 2009
CAPE TOWN, South Africa - Not For Distribution To South African Journalists ISENTRESS (R) (raltegravir), an integrase inhibitor from Merck Sharpe & Dohme (MSD) was as effective as efavirenz at maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 counts in previou


Piedmont Medical Group (PMG) Partners with East Tennessee State University
Business Wire - July 20, 2009
Collaboration Represents Groundbreaking Industry Model for Conducting Clinical Trials WINSTON-SALEM, N.C. - Piedmont Medical Group (PMG), a leader in the clinical research industry with an experienced Integrated Site Network (ISN) of clinical research facilities, and East Tennessee State University (ETSU), a Carnegie F


Press Conference: AHF Sues L.A. County to Require Condoms in Porn
Business Wire - July 17, 2009
LA Times Reports: The petition... asks the court to order the county public health department to enforce regulations that require condom use in adult film production or take other reasonable steps to stem the spread of disease. LOS ANGELES - AIDS Healthcare Foundation (AHF): WHAT: Press Conference and Teleconference


PolyMedix to Present at 5th International AIDS Society (IAS) Conference
Business Wire - July 17, 2009
Cape Town, South Africa | July 19 - 22, 2009 RADNOR, Pa. - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make a poster presentation at the 5th International AIDS So


The New Cannabis Science President & CEO Dr. Melamede Reports FDA Progress Plans And New Management Team Objectives for its Cannabis Formulations
Business Wire - July 17, 2009
SAN FRANCISCO - Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce that the Company is moving forward confidently under the guidance of its new President & CEO, Dr. Robert Melamede Ph.D. The planning for the company s product line up remains the same, inclu


New Delhi: AHF India Cares Launches 'LOVE Condom' Campaign
Business Wire - July 17, 2009
Campaign Kicks Off with Event Today - Includes Free Condom Distribution, Unveiling of Innovative Stay Negative Ad NEW DELHI - AIDS Healthcare Foundation (AHF) is launching its LOVE Condom campaign with an event today in the New Delhi region on the 18th of July, 2009. The campaign includes the distribution of free AHF


Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize New Fixed-Dose Combination of Truvada(R) and TMC278
Business Wire - July 16, 2009
-- Product Would Represent Second Truvada-Based Complete Fixed-Dose Regimen -- FOSTER CITY, Calif. - Gilead Sciences , Inc. (Nasdaq:GILD) today announced that it has entered into a license and collaboration agreement with Tibotec Pharmaceuticals for the development and commercialization of a new once-daily fixed-dose


AIDS Healthcare Foundation Opens 'Men's Wellness Center' at NorthPoint
Business Wire - July 15, 2009
Walk-In Clinic to Provide Free, Confidential Sexual Health Services -- Including HIV and STD Testing and Treatment -- in One Convenient Location FT. LAUDERDALE, Fla. - On Thursday, July 16th, AIDS Healthcare Foundation (AHF) will open a Men s Wellness Center at AHF NorthPoint Healthcare Center to provide free, confiden


Flowers Heritage Foundation Donates 500,000 Condoms to Non-Profit Organizations
Business Wire - July 13, 2009
Donations in San Francisco, Miami, Washington D.C., and Puerto Rico Represent Half of Foundation s One Million Condom Giveaway Goal OAKLAND, Calif. - The Flowers Heritage Foundation recently donated half a million condoms to non-profit organizations in San Francisco, Miami, Washington D.C, and Puerto Rico. The initiati


MMWR Report on Gonorrhea and Chlamydia Incidence among MSM Spurs AHF to Call for FDA Approval of Newer Testing Technologies
Business Wire - July 9, 2009
Five City Study of At-risk Men-who-have-Sex-with-Men (MSM) Found that NAA (nucleic acid amplification) Testing--a More Accurate and Respected Test for Gonorrhea and Chlamydia--is Seldom Used, as it has Not Yet Been Cleared by the FDA for Such Purposes AHF--A Clinical Participant in the Trial--Believes FDA Approval of N


Cytheris Announces Notice of Allowance for U.S. Patent Covering the Pharmaceutical Composition of Its Recombinant Human Interleukin-7 (CYT107)
Business Wire - July 8, 2009
PARIS - Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application IL-7 Drug Substance, Composition, Preparatio


IAVI and Theraclone Expand HIV Antibody Discovery Collaboration
Business Wire - July 06, 2009
SEATTLE & NEW YORK - Theraclone Sciences, Inc. and the International AIDS Vaccine Initiative (IAVI) have announced an expansion of their HIV antibody discovery program. In 2008, Theraclone was granted an award under IAVI s Innovation Fund to test its unique process for isolating, from the blood of certain HIV-infec


'AHF/India Cares' Commends Delhi High Court for Overturning Anti-Gay Law
Business Wire - July 03, 2009
Move by Delhi High Court to Decriminalize Homosexual Relations in India Should Help Reduce Widespread Stigma and May Help Reduce New HIV Infections in Hard-hit Country NEW DELHI - AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US and which operates free AIDS treatment clinics in India under the


County of San Bernardino Department of Behavioral Health Selects Ramsell Public Health Rx to Provide Pharmacy Benefit Management Services
Business Wire - July 01, 2009
OAKLAND, Calif. - Ramsell Public Health Rx, a pharmacy benefit and information management company, today announced it was selected to provide services for the County of San Bernardino s Department of Behavioral Health (DBH). DBH provides mental health treatment and services to County residents that promote prevention,


AHF Applauds Obama for Urging All Americans to Get Tested for HIV
Business Wire - June 30, 2009
President Encourages Effort to Find More than 230,000 HIV Positive, Undiagnosed Individuals, Those Thought to be the Source for Majority of 56,000 New HIV Infections in U.S. Each Year WASHINGTON - AIDS Healthcare Foundation (AHF), the nation s largest non-profit HIV/AIDS healthcare provider, praised President Obama s s


AHF's Magic Johnson 14 City Free HIV Testing Caravan a 'Watershed Moment' in Evolution of Testing Process
Business Wire - June 29, 2009
LA to DC: AHF s Successful Three Week, 4339 Mile Free HIV Testing Caravan Visited Hard-hit Southern US Cities; Worked with Respected Local Community Agencies and Provided 727 Free HIV Tests WASHINGTON - In an effort to raise local and national awareness about the importance--and ease--of HIV testing and to challenge at


VITAS Innovative Hospice Care Signs a National Agreement with UniCare
Business Wire - June 29, 2009
MIAMI - VITAS Innovative Hospice Care(R) announced an agreement with UniCare Life & Health Insurance Company (UniCare) that will provide UniCare members access to comprehensive hospice services in every market in which VITAS operates. UniCare and VITAS Innovative Hospice Care(R) both exemplify extraordinary experie


Nat'l. HIV Testing Day: AHF/Magic Johnson HIV Testing Caravan to Finish 14-City Cross-Country Testing Tour in Washington, DC, with Free Testing Events June 27 & 28
Business Wire - June 27, 2009
Vans to Offer Free HIV Testing at DC s Caribbean Carnival June 27th & 28th (1 p.m. to 5 p.m.) & in Washington Highlands (Ward 8) on June 27th (1 p.m. to 5 p.m.) LA to DC: Successful Three-Week, 14-City Free HIV Testing Caravan Visited Hard-Hit Southern US Cities; Over 500 Free Tests Performed Along the Route -


Statement by Kathleen G. Sebelius, Secretary of Health and Human Services, Regarding National HIV Testing Day--June 27, 2009
Business Wire - June 26, 2009
WASHINGTON - I am honored to join my colleagues and organizations such as the National Association of People with AIDS to recognize National HIV Testing Day on June 27. HIV continues to be a critical issue in the United States and around the world. Every nine and a half minutes, someone in the United States becomes inf


The AIDS Institute Names New Executive Director Michael Ruppal to Lead Organization
Business Wire - June 26, 2009
WASHINGTON - The Board of Directors of The AIDS Institute is pleased to announce that Michael Ruppal has been named executive director of the national organization effective immediately. Ruppal brings over 25 years of business management experience including over 13 years of non-profit management. He has been providing


Starbucks Coffee Company Reaffirms its Commitment to Rwandan and East African Coffee Farmers
Business Wire - June 26, 2009
KIGALI, Rwanda - As part of its ongoing commitment to east Africa, Starbucks Coffee Company (NASDAQ: SBUX) announced today that participating stores in the U.S. and Canada will offer for a limited time a selection of African coffees and other products from the region beginning next week. In addition, Starbucks executiv


Wide World of Stocks Debuts to Showcase Microcap Equities -- Viral Genetics, Inc. to Be Featured on Premier TV and Website Episode
Business Wire - June 26, 2009
PORT JEFFERSON, N.Y. - Wide World of Stocks, a new nationally syndicated television and website program that seeks to showcase undervalued microcap stocks, will launch its 30-minute taped television show and webcast, at www.wideworldofstocks.com, this week. The first company to be featured will be Viral Genetics, Inc.


Obama Administration Disappoints on AIDS with Latest Roadblocks to Routine Screening
Business Wire - June 25, 2009
On Eve of National HIV Testing Day, CMS Letter Reminds State Health Providers of 2006 CDC Recommendations for Routine HIV Screening, But Stops Short of Mandating Coverage WASHINGTON - On the eve of National HIV Testing Day, AIDS Healthcare Foundation (AHF), the nation s largest AIDS organization, today expressed its di


Clear Channel Joins Greater Than AIDS Campaign
Business Wire - June 25, 2009
Joint Media Campaign to Increase HIV/AIDS Awareness to African-American Communities Across the Nation SAN ANTONIO - Leading up to National HIV Testing Day (June 27th), Clear Channel Communications has joined the Black AIDS Media Partnership (BAMP) to promote the Greater Than AIDS campaign on its radio and outdoor platf


Miami-Dade County Health Department, Office of HIV/AIDS, to Launch Test Miami
Business Wire - June 25, 2009
MIAMI - The Miami-Dade County Health Department, Office of HIV/AIDS will launch Test Miami - an innovative and pivotal county-wide initiative promoting the Centers for Disease Control and Prevention (CDC) recommendation of HIV testing as part of routine clinical care in all health care settings - Thursday, June 25. Thi


OraSure Technologies Provides Update on Clinical Development Programs and OraQuick Manufacturing
Business Wire - June 25, 2009
BETHLEHEM, Pa. - OraSure Technologies, Inc. (NASDAQ:OSUR) today announced an update regarding the status of its application for U.S. Food and Drug Administration ( FDA ) approval of an OraQuick(R) Hepatitis C ( HCV ) test for professional use and its clinical program for an OraQuick(R) HIV-1/2 test for sale in the cons


Minnesota AIDS Project Recognizes National HIV Testing Day - Challenges Minnesotans to Know Their Status
Business Wire - June 24, 2009
MINNEAPOLIS - In observance of National HIV Testing Day on June 27, organizations in cities across the United States are encouraging those at risk to access voluntary HIV testing and counseling to know his or her HIV status. The Minnesota AIDS Project, the leading source for HIV information and services in the state, o


Chevron Receives Global Business Coalition's Leadership Award for Business Excellence
Business Wire - June 24, 2009
SAN RAMON, Calif. - Chevron Corporation (NYSE:CVX) will be recognized this evening by the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) for its longstanding commitment to fight the spread of HIV/AIDS, tuberculosis and malaria around the world. Chevron will receive the GBC s prestigious Richard C


International Association of Physicians in AIDS Care Partners With Healthy Interactions(R) to Advance HIV/AIDS Education Across Diverse Cultures, Patient Populations
Business Wire - June 24, 2009
CHICAGO - The International Association of Physicians in AIDS Care (IAPAC) today announced that it is entering into a partnership with global patient education innovator Healthy Interactions. The partnership will address the rising incidence of HIV/AIDS in both developed and developing world nations via culturally rele


LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc.
Business Wire - June 23, 2009
Acquisition Price of $4.55 per Share in All Cash Transaction LabCorp to Strengthen Leadership in Infectious Disease and Oncology and Advance Personalized Medicine Strategy BURLINGTON, N.C., SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and Monogram B


Charlotte, June 24th--AHF/Magic Johnson Testing Van Teams with Metrolina AIDS Project for Free HIV Testing Event
Business Wire - June 23, 2009
LA to DC: Three Week, 14 City Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday, June 27th--National HIV Testing Day CHARLOTTE, N.C. - AIDS Healthcare Foundation (AHF): What: FREE HIV TESTING EVENT AHF/Magic Johnson HIV Testing Van Continues Three Week, 14 City Southern US


Big Brands Aim to Bolster U.S. AIDS Efforts
Business Wire - June 23, 2009
$1 Million Contribution from Pfizer Supports GBC Initiative; National Campaigns and Initial Efforts in Three Hard-Hit Cities: Washington, D.C., Oakland and New York WASHINGTON - In response to near-epidemic levels of HIV/AIDS, particularly among minorities in some urban areas of the U.S., the Global Business Coalition


ATLANTA, June 22nd--AHF/Magic Johnson Testing Van Teams with AID Atlanta, Inc. for Free HIV Testing Event
Business Wire - June 22, 2009
LA to DC: Three Week, 14 City Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th--National HIV Testing Day AID Atlanta, Inc. Partners with AHF in Georgia Event ATLANTA - AIDS Healthcare Foundation: What: FREE HIV TESTING EVENT AHF/Magic Johnson HIV Testing Van Con


NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
Business Wire - June 22, 2009
WEST HAVEN, Conn. - NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), announced today that its CEO, Dr. Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles and applications , at the 3rd International Congress of NanoBiote


ICF International Awarded Contract with NIH Valued at More Than $60M: Firm to Provide Biomedical and Clinical Information Services
Business Wire - June 22, 2009
FAIRFAX, Va. - ICF International (NASDAQ:ICFI) health informatics group was awarded a new five-year contract valued at more than $60 million with the National Institutes of Health (NIH). Through this multi-year contract, ICF will provide support for biomedical and clinical services, such as data collection and analysis


ABL Settles Its Dispute with Stanford University and Endorses Stanford's HIVdb Website and Other Globally Available Research and Not-for-Profit Websites
Business Wire - June 22, 2009
LUXEMBOURG - Advanced Biological Laboratories SA (ABL) announced today that it has signed a Patent Immunity Agreement and has dismissed all claims against Stanford University, thus resolving any disputes related to ABL US patents 6.081.786, 6.188.988 and their foreign equivalents, ensuring the free access for all uses


Settlement Agreement between Advanced Biological Laboratory SA and Dr Robert Shafer
Business Wire - June 22, 2009
LUXEMBOURG - ABL SA is pleased to have reached a settlement, resolving the allegations that have been made about its relations and intent with respect to Dr Robert Shafer, associate professor at Stanford University, and the HIVdb website, which it believes were based on a misinterpretation of its intentions. ABL renews


Columbia, SC, June 23rd--AHF/Magic Johnson Testing Van Teams with South Carolina HIV/AIDS Council for Free HIV Testing Event
Business Wire - June 22, 2009
LA to DC: Three Week, 14 City Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th--National HIV Testing Day COLUMBIA, S.C. - AIDS Healthcare Foundation: What: FREE HIV TESTING EVENT AHF/Magic Johnson HIV Testing Van Continues Three Week, 14 City Southern US Testing


Condoms in Porn--State Law & AHF's Advocacy with LA County to Require Condom Use in Films
Business Wire - June 19, 2009
County Asleep at Switch on HIV Infections in Porn Industry; AHF to Call on Health Officials to Use Existing California Law to Stop Spread of STDs, including HIV Media Availability--Friday, June 19th All Day LOS ANGELES - AIDS Healthcare Foundation: WHAT: Media Availability--For Any Additional Follow up on AHF s Call on


150 Days: Obama's Silence on AIDS Remains Deafening
Business Wire - June 19, 2009
Campaign to Prod President Obama to Act on AIDS has Included Thought-Provoking Viral Videos, an Ongoing eLetter-Writing Campaign, a Controversial D.C. Bus Shelter Ad AIDS is DC s Katrina, and an Interactive Website: www.changeAIDSobama.org WASHINGTON - On the observation of President Obama s first 150 days in office, A


Jacksonville, June 20th-- AHF/Magic Johnson Testing Van Teams with JASMYN for Free HIV Testing Event
Business Wire - June 18, 2009
LA to DC: Three-Week, 14-City Free HIV Testing Caravan Visits Hard-Hit Southern U.S. Cities; Arrives in Washington, D.C., on Saturday, June 27th -- National HIV Testing Day Jacksonville Area Sexual Minority Youth Network Partners with AHF in North Florida Event - AIDS Healthcare Foundation (AHF): WHAT: FREE HIV TESTING


June 18th: AHF/Magic Johnson Testing Van Teams with Montgomery AIDS Outreach for Free HIV Testing Event
Business Wire - June 18, 2009
Event is Part of Fourteen-City, Three-Week, Cross-County AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, DC.: Free HIV Testing and AIDS Awareness Caravan Visits Hard-hit Southern Cities; Arrives D.C., on Saturday June 27th--National HIV Testing Day MONTGOMERY, Ala. - AIDS Healthcare Foundation: Wh


AHF to L.A. County: Shut Down Porn Sets
Business Wire - June 18, 2009
County Asleep at Switch on HIV Infections in Porn Industry; AHF to Call on Health Officials to Use Existing California Law to Stop Spread of STDs, including HIV Press Conference and Teleconference -- Thursday, June 18th, 1:00 pm Pacific LOS ANGELES - AIDS Healthcare Foundation (AHF) will host a press conference and tel


Continuing VA endoscope contamination problem unacceptable, says The American Legion: Legion leader calls for immediate action to eliminate health risks
Business Wire - June 17, 2009
WASHINGTON - The national commander of the nation s largest veterans service organization is expressing outrage at continuing instances of VA medical personnel exposing their patients to infectious diseases. The Department of Veterans Affairs Office of the Inspector General (IG) released a report Tuesday detailing a pa


Unique Collaboration between TB Alliance and Tibotec to Accelerate Tuberculosis Drug Development
Business Wire - June 17, 2009
Collaboration will focus on the development of TMC207 and the discovery of new drugs to treat tuberculosis SEATTLE - A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical com


Lab Express Honors National HIV Testing Day, by Providing Free HIV Tests on June 27
Business Wire - June 17, 2009
Those Who Miss Out on Free Test Can Purchase Test at Lab Express Cost of Only $25 June 27 Through July 31 PHOENIX - Lab Express, one of Arizona s largest independent medical testing companies, is going to provide TEN FREE 10-Minute HIV Tests at their central Phoenix location (505 W. McDowell). In addition the company h


Quintiles Increases Capacity to Manage Clinical Studies for Diseases Including Malaria, HIV and Tuberculosis
Business Wire - June 16, 2009
Announces New Office in Ghana , Collaboration with Noguchi Memorial Institute RESEARCH TRIANGLE PARK, N.C. - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana.


Mobile Aspects Solution Targets Improving Endoscope Safety
Business Wire - June 16, 2009
PITTSBURGH - With the heightened concerns around the safety and quality of patient care associated with the use of flexible endoscopes, Mobile Aspects announced the general availability of their endoscope tracking system, iRIScope™. Debuted recently at the Annual Course of the Society of Gastroenterology Nurses and Ass


June 18th: AHF/Magic Johnson Testing Van Teams with Montgomery AIDS Outreach for Free HIV Testing Event
Business Wire - June 16, 2009
Event is Part of Fourteen-City, Three-Week, Cross-County AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, DC.: Free HIV Testing and AIDS Awareness Caravan Visits Hard-hit Southern Cities; Arrives D.C., on Saturday June 27th--National HIV Testing Day MONTGOMERY, Ala. - AIDS Healthcare Foundation: Wh


CytoDyn Explains How Documentary Movies Are Made
Business Wire - June 15, 2009
LOS ANGELES - As previously reported on May 11, 2009, Evolution Media of Burbank, CA is producing a video documentary about Cytolin®, the first immune modulator for treating HIV/AIDS that has consistently shown serological and clinical benefits in early human experience. It is the lead drug of CytoDyn, Inc. (Pink Sheet


AMA Speech Continues Obama's Baffling Silence on AIDS
Business Wire - June 15, 2009
In Address to American Medical Association , President Urges Increased Prevention Efforts for Costly Diseases including Cancer, Cardiovascular Disease, Diabetes, Lung Disease and Strokes; Respected Institute of Medicine Study Found Lifetime Costs of Care for One AIDS Patient Tops $600,000 After Slashing Funding for


June 17th: AHF/Magic Johnson Testing Van to Host Free HIV Testing Event at Univ. of W. Florida
Business Wire - June 15, 2009
Event is Part of Fourteen-City, Three-Week, Cross-County AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, DC.: Free HIV Testing and AIDS Awareness Caravan Visits Hard-hit Southern Cities; Arrives D.C., on Saturday June 27th--National HIV Testing Day PENSACOLA, Fla. - AIDS Healthcare Foundation: What


June 15th--AHF/Magic Johnson HIV Testing Caravan, NO/AIDS, FACES & Family Health Center to Host Free HIV Testing Events at Cafe Du Monde & Algiers
Business Wire - June 15, 2009
Event is Part of Fourteen-City, Three-Week, Cross-County AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, D.C.: Free HIV Testing and AIDS Awareness Caravan Visits Hard-hit Southern Cities; Arrives D.C., on Saturday June 27th--National HIV Testing Day NEW ORLEANS - AIDS Healthcare Foundation: What: TWO


WeHo Gay Pride Parade: AHF's "Muscle Man" Balloon Urges People to 'Man Up! Use a Condom, Get Tested'
Business Wire - June 14, 2009
AHF s CSW Parade Contingent Marks Reappearance of Novelty Balloon Promoting HIV Testing Sunday, June 14th 11:00am WEST HOLLYWOOD, Calif. - AIDS Healthcare Foundation (AHF): What: Media Availability--AHF officials available to discuss -- AHF s Man Up HIV testing campaign -- AHF to renew its call for condoms in porn le


CSI Appoints Former Upjohn Senior Research Scientist Mary J. Ruwart, Ph.D. to Vice President of Research & Deveopment (VP R&D) Further Expanding Its Team of Drug Development Specialists
Business Wire - June 12, 2009
SAN FRANCISCO - Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce the appointment of Dr. Mary J. Ruwart as Vice President of Research & Development. Dr. Ruwarts previously held the position of Senior Research Scientist at Upjohn Inc., which ultimately


June 15th--AHF/Magic Johnson HIV Testing Caravan, NO/AIDS, FACES & Family Health Center to Host Free HIV Testing Events at Cafe Du Monde & Algiers
Business Wire - June 12, 2009
Event is Part of Fourteen - City, Three - Week, Cross - Country AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, D.C.: Free HIV Testing and AIDS Awareness Caravan Visits Hard - hit Southern Cities; Arrives D.C. on Saturday June 27th--National HIV Testing Day NEW ORLEANS - AIDS Healthcare Foundation:


June 13th: AHF/Magic Johnson Testing Van Teams with Legacy for Free HIV Testing at Juneteenth Festival
Business Wire - June 12, 2009
Event is Part of Fourteen - City, Three - Week, Cross - County AHF/Magic Johnson HIV Testing Tour from Los Angeles to Washington, DC.: Free HIV Testing and AIDS Awareness Caravan Visits Hard - hit Southern Cities; Arrives D.C., on Saturday June 27th--National HIV Testing Day HOUSTON - AIDS Healthcare Foundation: Wh


California: AHF Renews Call for 'Condoms in Porn' Legislation after L.A. Actress Tests HIV+
Business Wire - June 11, 2009
US Largest AIDS Group Previously Sought Legislation Requiring Condom Use in Adult Film Industry LOS ANGELES - After the Los Angeles Times reported today that an actress in the adult entertainment industry recently tested HIV - positive, the AIDS Healthcare Foundation (AHF) renewed its call for California legislation th


Change to Win: More Than 200 Organizations Call on CVS to Stop Practice of Locking Condoms, Adopt National Policy
Business Wire - June 11, 2009
CVS at least three times more likely to lock condoms in communities of color in many markets, according to Cure CVS WASHINGTON - A national coalition of more than 200 community organizations, health care educators and advocates announced today they are uniting in an effort to stop CVS Caremark Corp. from locking condom


Hundreds of Organizations to Call on CVS to Stop Practice of Locking Condoms, Adopt National Policy
Business Wire - June 11, 2009
CVS at Least Three Times More Likely to Lock Condoms in Communities of Color in Many Markets, According to Cure CVS WASHINGTON - A national coalition of hundreds of community organizations, health care educators and advocates are expected to announce on Thursday June 11, 2009 that they are uniting in an effort to stop


Media Advisory: CARE CEO to Be Featured Speaker at Stanford Medical School Graduation
Business Wire - June 09, 2009
STANFORD, Calif. - When she started her medical career 30 years ago as a pediatrician, Helene Gayle, MD, MPH, said she never imagined she d find herself at the helm of one of the world s biggest poverty - fighting organizations. Now the president and CEO of CARE, Gayle has reinvented herself along the way, continually


AHF/Magic Johnson HIV Testing Caravan & New Mexico AIDS Services to Host Free HIV Testing Event at Fourth Street Mall - Wednesday June 10th 4:00PM to 7:00PM
Business Wire - June 09, 2009
LA to DC: Three Week, 14 City Free Mobile HIV Testing Caravan Visits Hard-Hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th--National HIV Testing Day


Blair Underwood to Kick Off AHF's U.S. HIV Testing Caravan - Monday, June 8th, 11:00AM (PDT)
Business Wire - June 08, 2009
LA to DC: Three Week, 14 City Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th--National HIV Testing Day


AHF to Schwarzenegger: 'AIDS Cuts Are Deadly'
Business Wire - June 5, 2009
AIDS Groups & Patients to Protest in LA: Governor Should Cut Bureaucracy, Corporate Loopholes Not Lifesaving AIDS Services HOLLYWOOD, Calif. - AIDS Healthcare Foundation: What: RALLY & PROTEST--Catastrophic Cuts to California AIDS Services When: FRIDAY, June 5th 5:00 pm - 7:00 pm Where: Hollywood Forever Cemete


Lifesong 2009: Applaud and Pause for a Cause Uses Star-Power to Fight HIV
Business Wire - June 4, 2009
MINNEAPOLIS - Because We Care (BWC) is pleased to present Lifesong 2009: Applaud and Pause for a Cause, hosted by Broadway star, acclaimed writer, and television personality, Bruce Vilanch, on Saturday, June 20, at 7 p.m. The event, held at the Music Box Theatre in downtown Minneapolis, features performances by more th


Positive Outcome Reached at 16 Weeks for Avexa's ATC Phase III Trial
Business Wire - June 4, 2009
* DSMB recommends continuation of the ATC Phase III Trial after review of the data * Lower, 800mg dose selected to use going forward * 800mg dose more conducive to fixed dose combinations MELBOURNE, Australia - Avexa Limited (ASX:AVX) announced that the Data Safety Monitoring Board (DSMB) met today to review the 16 wee


Dicerna Pharmaceuticals to Present at Upcoming RNAi-Focused Scientific Conferences
Business Wire - June 4, 2009
Dicer Substrate Technology(TM) Subject of June Presentations at CHI s RNA Interference Summit, SMi s RNAi, siRNA & miRNA Conference and Keystone Symposium on Molecular and Cell Biology WATERTOWN, Mass. - Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utiliz


The Deadbeat State: California Sued for Not Paying Savings to State's Largest AIDS Group
Business Wire - June 2, 2009
State refuses to pay nearly $1M in Money Owed to AHF s Positive Healthcare AIDS Care Plan; Move Creates Disincentive for Other State Vendors, Care Providers to Save Money As State Bureaucrats Pursue Short-sighted, Punitive Ways to Try and Reduce Costs, Superior Court Action is among First Filed against State since Cali


Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
Business Wire - June 02, 2009
LEXINGTON, Mass. & LONDON - Concert Pharmaceuticals and GlaxoSmithKline (NYSE: GSK) announced today that they will collaborate to develop and commercialize deuterium-containing medicines. The deal includes three of Concert s research and development programs; namely, CTP-518, a protease inhibitor for the treatment


BioSante Pharmaceuticals Comments on Benefits of Testosterone Use in HIV-Infected Women
Business Wire - June 02, 2009
Research Published in Journal of the International AIDS Society LINCOLNSHIRE, Ill. - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), which is developing a testosterone gel (LibiGel(R)) for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, today commented on a paper published in the May 15, 2


Hollywood Whodunit: Thieves Hit Sunset Boulevard -- AHF's 15 Ft Muscle Man Balloon Promoting HIV Testing, "Gone with the Wind"
Business Wire- May 28, 2009
HOLLYWOOD - In a literal, if not classic second story job, the AIDS Healthcare Foundation (AHF), the nation s largest AIDS organization, today reported an unusual Hollywood Whodunit: a 15 foot high inflatable muscle man balloon sporting a sash to promote free HIV testing and other AIDS services was stolen under cover o


QIAGEN to Supply Molecular Screening Solutions to Increase Safety of Blood Donations in Brazil
Business Wire- May 28, 2009
Agreement Covers Reagents and Instruments for Testing Samples For HIV and HCV VENLO, Netherlands - QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it has entered into an agreement to supply molecular sample and assay technologies for a new national, PCR-based blood screening program for HIV an


Mandarin Oriental Dellis Cay Experience Auctioned off for Charity at Formula One Grand Prix in Monaco
Business Wire- May 27, 2009
MONACO, France - MANDARIN ORIENTAL DELLIS CAY EXPERIENCE AUCTIONED OFF FOR CHARITY AT FORMULA ONE GRAND PRIX IN MONACO On Friday, May 22, 2009, Dr. Cem Kinay, CEO & Chairman of The O Property Collection (OPC), donated a Mandarin Oriental Dellis Cay Luxury Experience on his exclusive Caribbean island for the charity


Roche Launches New PCR Assay for Tuberculosis Testing in South Africa
Business Wire- May 26, 2009
PENZBERG, Germany - Roche Diagnostics today announced the launch of a new tuberculosis test for South Africa . Worldwide, South Africa is one of the countries with the highest prevalence of tuberculosis. The new kit detects different species of Mycobacterium from human sputum samples using the LightCycler(R) 2.


California's AIDS Funding Cuts Would Be 'Catastrophic,' Says AHF
Business Wire - May 22, 2009
Slash and Burn Approach is Wrong-headed Way for State to Handle Public Health Epidemic Cuts--Including $96M from Lifesaving AIDS Drug Assistance Program--Would Trigger Vast Additional Lost Federal and Private AIDS Dollars; Proposal to Take All Money for AIDS Care and Treatment from General Fund Could be Death Sentence


CVS Selling Expired Products, Locking Condoms in Atlanta, Says Change to Win
Business Wire- May 21, 2009
Warning to Consumers Issued by Community Leaders ATLANTA - A new study released today shows 69% of local CVS drugstores surveyed are selling expired products, among other issues. In reaction to the news, a delegation of community and faith leaders held a demonstration outside a local CVS pharmacy today to challenge CVS


THE BATCH IS BACK! Ben & Jerry's Launches Limited Elton John Flavor Nationally to Raise Money for the Elton John AIDS Foundation
Business Wire- May 20, 2009
Goodbye Yellow Brickle Road Makes Its National Stage Debut BURLINGTON, Vt. - The people have spoken. After launching a one-week, limited edition flavor to recognize Sir Elton John s first trip to Vermont and to raise money for the Elton John AIDS Foundation (EJAF), Ben & Jerry s has heard enough. Fans of Elton John


Kaiser Permanente Educational Theatre Presents "What Goes Around" at Blair High School
Business Wire- May 20, 2009
Actor/Educators Bring Messages about Abstinence, HIV Testing and Epidemic Rates of STDs PASADENA, Calif. - To raise awareness about abstinence, HIV testing and the epidemic rate of STDs in a way that gets the attention of the audience, Blair High School invited Kaiser Permanente s Educational Theatre Programs (ETP) fiv


Sir Elton John Delivers Keynote Today at 2009 BIO International Convention
Business Wire- May 19, 2009
Renowned AIDS Activist Addresses Biotech s Role in HIV/AIDS Prevention, Treatment 2009 BIO International Convention ATLANTA - Sir Elton John delivered today s keynote address at the 2009 BIO International Convention at the Georgia World Congress Center in Atlanta. He focused on the HIV/AIDS epidemic, how biotechnology


Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need for Next Generation Treatments
Business Wire- May 19, 2009
BIO Challenges Biotech Community to Help Benefit Elton John AIDS Foundation 2009 BIO International Convention ATLANTA - Leaders in biotechnology research and patient advocacy joined forces today at the 2009 BIO International Convention to discuss the latest breakthroughs in HIV/AIDS treatments. Following a keynote spee


RED Joins Kellogg Innovation Network as Vision Partner for KIN Global 2009
Business Wire - May 19, 2009
Collaboration is Part of KIN s Efforts to Engage in Broader Public Dialogue toward Building Global Prosperity CHICAGO - The Kellogg Innovation Network (KIN) at Northwestern University s Kellogg School of Management announced today that (RED), which engages business and consumer power in an effort to help eliminate AIDS


Upcoming BioAlliance Pharma's Presentations at International Conferences on Infectious Diseases and Oncology
Business Wire - May 19, 2009
PARIS - Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to therapies and supportive care for cancer and AIDS patients, today announced its scientific communications at upcoming international conferences on infectious diseases and oncology: Loramyc(R), indicated for fungal infections in immune-co


Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation
Business Wire - May 19, 2009
2009 BIO International Convention SEATTLE - Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that its Scientific Advisory Board (SAB) completed a comprehensive review of the current in vitro and in vivo data for its lead HIV drug, KP-1461. The


HHS Secretary Sebelius Addresses World Health Assembly Plenary Session
Business Wire - May 18, 2009
WASHINGTON - This morning, Health and Human Services Secretary Kathleen Sebelius addressed the World Health Assembly Plenary Session. Sebelius remarks as prepared for delivery are included below: Mr. President, Madam Director-General, fellow delegates: It is my honor to represent the United States of America and


New Data for Gilead Sciences' Ambrisentan Show Clinical Improvements in a Diverse Pulmonary Hypertension (PH) Population
Business Wire - May 18, 2009
SAN DIEGO - Gilead Sciences , Inc. (Nasdaq: GILD) today announced results from ARIES-3, an open-label, single-arm, Phase III study evaluating the efficacy and safety of ambrisentan in patients with pulmonary hypertension (PH), which showed a mean 21-meter improvement from baseline in six-minute walk distance (6MWD) at


New Report Forecasts Hepatitis C Virus Epidemic Among Baby Boomers; Untreated HCV Progressing to Severe Liver Disease Seen Driving U.S. Costs to $85 Billion
Business Wire - May 18, 2009
-Over 3 million Americans have chronic hepatitis C – -Baby boomers account for 2 of every 3 cases of hepatitis C virus and vast majority unaware they have this chronic disease - -Cost burden of hepatitis C to Medicare projected to increase 500% as baby boomers with HCV age into severe complications of liver disease-


Collaboration Agreement between Monogram and Pfizer Extended
Business Wire - May 18, 2009
SOUTH SAN FRANCISCO, Calif. - Monogram Biosciences, Inc. (Nasdaq:MGRM) today announced that its partner Pfizer Inc has exercised its right to extend the Collaboration Agreement between Monogram and Pfizer. The adjustments to our collaboration with Pfizer strengthen the platform for commercialization of Trofile and indi


ViroStatics' Dr. Franco Lori to Present During 2009 BIO International Convention in Atlanta
Business Wire - May 18, 2009
2009 BIO International Convention SASSARI, Italy & PRINCETON, N.J. - Dr. Franco Lori, Chief Executive Officer of ViroStatics, will present a Company Overview during the 2009 BIO International Convention at 9:20 AM on Wednesday, 20 May, 2009 in Atlanta, Georgia, USA. Dr. Lori will discuss the Company s recent advanc


AIDS Patients with Serious Complications Benefit from Early Retroviral Use, Stanford Study Shows
Business Wire - May 15, 2009
STANFORD, Calif. - HIV-positive patients who don t seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University Schoo


NYC's Frieden Brings 'Real World Experience Fighting AIDS' to CDC
Business Wire - May 15, 2009
US Largest AIDS Group Hopes White House Appointment Indicates Obama Will End Silence on AIDS WASHINGTON - AIDS Healthcare Foundation (AHF) (http://www.aidshealth.org), the largest non-profit HIV/AIDS organization in the US which currently provides medical care and services to more than 100,000 individuals in 21 countri


HemoBioTech to Present Blood Substitute Strategy at RENN Capital Investor Conference
Business Wire - May 15, 2009
DALLAS - HemoBioTech (OTCBB:HMBT) (www.hemobiotech.com) announced today that Dr. Arthur P. Bollon, Chairman & CEO, will present the development strategy for its blood substitute, HemoTech, at the RENN Capital Investor Conference on May 15, 2009. Dr. Bollon will discuss the global need for a safe blood substitute as


New Advances on the Long Road to the Development of an AIDS Vaccine - A statement from Dr. Seth Berkley of the International AIDS Vaccine Initiative
Business Wire - May 15, 2009
NEW YORK - World AIDS Vaccine Day, May 18, marks the occasion in 1997 when U.S. President Bill Clinton challenged researchers to come up with an AIDS vaccine within the following decade, stating that such a vaccine was the only way to eliminate the threat of AIDS. Twelve years later, the goal of an effective HIV vaccin


HHS to Award $1.79 Billion to Help People Living with HIV/AIDS
Business Wire - May 14, 2009
WASHINGTON - The U.S. Department of Health and Human Services (HHS) today announced the release of $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications. The grants are funded through the Ryan White HIV/AIDS Program, which helps more than 529,000 ind


ViraCor Laboratories Launches Ultrasensitive JC Virus Test
Business Wire - May 13, 2009
New test will assist in the earlier diagnosis of Progressive Multifocal Leukoencephalopathy, a serious brain infection exclusively caused by JCV KANSAS CITY, Mo. - ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new ultrasensitive molecular test


Argos Therapeutics Announces Participation at BIO 2009 International Convention
Business Wire - May 13, 2009
DURHAM, N.C. - Argos Therapeutics today announced its participation in an HIV/AIDS press event, a breakout panel session and the Business Forum partnering system at the BIO 2009 International Convention, held May 18-21, 2009, at the Georgia World Congress Center in Atlanta. Argos President and Chief Executive Officer,


Nine Pioneers Form Los Angeles Credit Unions for Kids Advisory Board
Business Wire - May 12, 2009
LOS ANGELES - Nine veterans of the Southland s credit union community have teamed up to form the first local Credit Unions for Kids Advisory Board for Childrens Hospital Los Angeles. The Credit Unions for Kids Advisory Board is the first of its kind in the nation and will spearhead the charge to gain support from South


Cytheris Announces Publication of IL - 7 Primate Study Showing Rapid and Massive T Cell Homing to the Gut
Business Wire - May 12, 2009
Results Suggest Potential of IL - 7 in Stimulating the T - Cell Repopulation of the Gut, Which is Inaccessible to HAART Therapy and Constitutes a Potent Viral Reservoir Where HIV - 1 Continues to Replicate and Suppress Immune Function PARIS - Cytheris SA, a clinical stage biopharmaceutical company focused on research a


Inhibitex Reports First Quarter 2009 Financial Results
Business Wire - May 12, 2009
ATLANTA - Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the first quarter ended March 31, 2009. The Company held cash, cash equivalents and short - term investments of $29.2 million at March 31, 2009, as compared to $33.1 million at December 31, 2008.


Concert Pharmaceuticals Granted Patents on Deuterium - Modified Compounds
Business Wire - May 11, 2009
LEXINGTON, Mass. - Concert Pharmaceuticals, Inc. announced today that its first patents have been granted by the U.S. Patent and Trademark Office. These patents relate to specific compounds derived from Concert s deuterium chemistry platform. U.S. Patents 7,514,068 and 7,528,131 specifically claim deuterium analogs of


Independent TV Producer Taping Documentary About CytoDyn
Business Wire - May 11, 2009
LOS ANGELES - CytoDyn, Inc. (Pink Sheets: CYDY) is featured in a documentary about its lead product Cytolin(R), the first immune based drug for HIV/AIDS that has been successfully used in about 200 patients to prevent the human immune system from self - destructing in response to HIV infection. This story was previousl


Progenics Announces First Quarter Financial Results
Business Wire - May 11, 2009
TARRYTOWN, N.Y. - Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the quarter ended March 31, 2009.


L.A. County Cuts Vital AIDS Medical Services: Despite Receiving $2.5 Million in Additional Ryan White CARE Act Funds for AIDS Services, County Bureaucrats Slash $600,000 in Funding that Provides Direct HIV/AIDS Medical Care--Including Lifesaving AIDS Drugs--to Some of L.A.'s Most Vulnerable Citizens
Business Wire - May 08, 2009
AHF Urges People to Call & Write L.A. County s Dr. Jonathan Fielding to Demand He Halts the Cuts LOS ANGELES - First graph, first sentence of release should read: L.A. County s Department of Public Health (sted: L.A. County s Department of Health Services (DHS)). The corrected release reads: L.A. COUNTY CUTS VITAL


Inhibitex Initiates Phase II Clinical Trial of FV - 100 for the Treatment of Shingles
Business Wire - May 08, 2009
ATLANTA - Inhibitex, Inc. (Nasdaq: INHX), a biopharmaceutical company focused on developing products to treat infectious diseases, today announced that it has initiated a Phase II clinical trial with FV - 100, its oral antiviral compound in clinical development for the treatment of herpes zoster (shingles). The Phase I


Ardea Biosciences Reports Recent Accomplishments and First Quarter 2009 Financial Results
Business Wire - May 08, 2009
Restructuring to Focus Company on Clinical - Stage Programs SAN DIEGO - Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small - molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), cancer and inflammatory diseases, today reported recent accom


Trimeris Reports Financial Results for the First Quarter 2009
Business Wire - May 08, 2009
DURHAM, N.C. - Trimeris, Inc. (Nasdaq: TRMS) today announced financial results for the quarter ended March 31, 2009, reporting net income of $2.1 million, or $0.10 per share compared with $2.3 million, or $0.10 per share for the quarter ended March 31, 2008. This result was primarily driven by decreased FUZEON(R) sales


HHS Budget Puts Reform First
Business Wire - May 07, 2009
Budget Helps Control the Skyrocketing Cost of Health Care, Cuts Waste & Fraud from Medicare and Protects Public Health WASHINGTON - Citing the rapidly escalating cost of health care in this country and the enormous pressures that health care costs are putting on our economic future, Health and Human Services Secret


AHF Goes Viral with Safer-Sex, AIDS Advocacy Videos — Reaches 9 Million Viewers
Business Wire - May 07, 2009
LOS ANGELES - To complement its traditional media strategy, AIDS Healthcare Foundation (AHF), the US’ largest nonprofit HIV/AIDS healthcare provider, has recently gone viral, reaching millions of online users with its innovative HIV/AIDS advocacy and prevention campaigns distributed on the internet. Utilizing video and


Chevron Issues 2008 Corporate Responsibility Report
Business Wire - May 06, 2009
* Invested $160 million in community initiatives around the world * Posted record safety performance * Completed major energy efficiency projects and reduced GHG emissions SAN RAMON, Calif. - Chevron Corporation (NYSE: CVX) invested $160 million in communities around the world, posted record safety performance and comp


OraSure Announces 2009 First Quarter Financial Results
Business Wire - May 06, 2009
BETHLEHEM, Pa. - OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $17.3 million for the three months ended March 31, 2009, compared to $18.1 million recorded for the three months ended March 31, 2008. Increased sales of the Company s OraQuick ADVANCE(R) ra


Monogram Announces 2009 First Quarter Financial Results - Conference Call Today at 4:30 p.m. ET
Business Wire - May 06, 2009
SOUTH SAN FRANCISCO, Calif. - Monogram Biosciences, Inc. (Nasdaq:MGRM) today reported financial results for the quarter ended March 31, 2009.


MedAssets Honors Two Charities with Humanitarian, Volunteer Awards
Business Wire - May 05, 2009
ATLANTA - MedAssets Inc. (NASDAQ: MDAS) recognized individuals with two charitable organizations whose work helps orphaned African children and returning disabled veterans, respectively, with humanitarian and volunteer-based awards at its annual Healthcare Business Summit. MedAssets awards a person or team in the healt


Leading Vaccine Discovery Expert Joins the International AIDS Vaccine Initiative (IAVI)
Business Wire - May 05, 2009
NEW YORK - Dr. C. Richter (Rick) King, former Senior Vice President of Research at GenVec, Inc., has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Vaccine Discovery. In his new position, Dr. King will play a vital role in leading and managing IAVI s global vaccine discovery initiatives in


PolyMedix to Present at 22nd International Conference on Antiviral Research (ICAR)
Business Wire - May 05, 2009
Miami Beach Resort & Spa, Miami, Florida, USA | May 3rd - May 7th, 2009 RADNOR, Pa. - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make a poster presentation a


Lifeline Program(R) Celebrates 20 Years in Life Insurance Settlement Industry
Business Wire - May 05, 2009
ATLANTA - The Lifeline Program(R) this month celebrates 20 years in the life insurance settlement industry as it embarks an aggressive new emphasis on the proper aggregation of custom life settlement portfolios for major financial institutions and hedge funds. The Lifeline Program is one of the oldest and most respecte


Two District of Columbia Youth Honored for Volunteerism at National Award Ceremony
Business Wire - May 04, 2009
Former First Lady Laura Bush Pays Tribute to Young Heroes as Part of Four-Day Recognition Events WASHINGTON - Two District of Columbia students, Lawrence Manley, 18, and Krysten Thomas, 17, were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2009 Prudentia


'Congressional Quarterly' Piece Focuses on Obama's Silence on AIDS
Business Wire - May 04, 2009
Article Titled AIDS Group Shows Impatience in Today s Issue Highlights AHF TV Ad Which Hopes to Prod President Obama to Act on HIV/AIDS WASHINGTON - An article in today s issue of Congressional Quarterly headlined, AIDS Group Shows Impatience, focuses on AIDS Healthcare Foundation s growing concern that President Obama


PolyMedix Presents Anti-tuberculosis Data at 5th European Conference on Clinical and Social Research on AIDS and Drugs
Business Wire - April 30, 2009
Vilnius, Lithuania 28 - 30 April 2009 RADNOR, Pa. - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, is making a poster presentation this week at the 5th European Conferenc


Levi Strauss Foundation Provides Cash Grants to San Francisco LGBT and HIV/AIDS Nonprofits
Business Wire - April 30, 2009
Levi Strauss & Co. employees to volunteer on 501 Day at organizations that serve the local LGBT and HIV/AIDS community SAN FRANCISCO - On May 1, 501 Day, Levi Strauss & Co. (LS&CO.) employees across the United States will take the day off from their usual work to volunteer with nonprofit organizations in th


New England Journal of Medicine Publishes Landmark Clinical Studies of the Investigational Hepatitis C Virus Protease Inhibitor Telaprevir
Business Wire - April 29, 2009
CAMBRIDGE, Mass. - Two clinical studies published in this week s New England Journal of Medicine demonstrate that treatment with the investigational oral hepatitis C virus (HCV) protease inhibitor telaprevir dosed in combination with pegylated-interferon (peg-IFN) and ribavirin (RBV) as part of a 24-week treatment regi


CHI's Patient Perspectives Podcast Series: Loring Leeds: HIV Patient's Experience Finding "Miracle Cure": Podcast examines one patient's experience trying to find treatment for HIV
Business Wire - April 29, 2009
LA JOLLA, Calif. - Please join CHI-California Healthcare Institute as we release the first installment of a new podcast series, Patient Perspectives. The series will examine patient experiences throughout the healthcare continuum, and touch on topics ranging from access to information and care, to breakthrough research


AHF Lauds Obama's Appointment of Dr. Eric Goosby at PEPFAR
Business Wire - April 27, 2009
US Largest AIDS Group Urges White House to Ensure Goosby has the Support and Resources Necessary to Effectively Lead Lifesaving Global AIDS Program. New Global AIDS Coordinator Brings Years of Experience Working in Global AIDS Fight. WASHINGTON - AIDS Healthcare Foundation (AHF) today lauded President Obama s choice of


Bristol-Myers Squibb Announces Call for Entries for the 2009 REYATAZ(R) (atazanavir sulfate) "Fight HIV Your Way" Contest: Photographs with essays and videos that express the fight against HIV
Business Wire - April 27, 2009
PRINCETON, N.J. - Bristol-Myers Squibb Company (NYSE: BMY) today announced the call for entries for the REYATAZ(R) ( atazanavir sulfate) Fight HIV Your Way Contest for photographs with essays or videos that express the individual fight against HIV/AIDS of people who are infected with or affected by the disease.


Obama's 100 Days of Silence on AIDS Challenged in AHF TV Ad
Business Wire - April 26, 2009
60-Sec. Ad Compares Him to Former Presidents Reagan, Bush, Clinton and Bush and States: President Obama: We Hope You are the Change We Can Believe in on AIDS Over 1 Million People Have Visited the Campaign Website, More Than 1,000 e-Letters Have Been Sent to President Obama WASHINGTON - AIDS Healthcare Foundation (AHF)


Telaprevir Data Presented at EASL Show Unprecedented SVR Rates in HCV Treatment-Failure Patients in PROVE 3 Study
Business Wire - April 25, 2009
COPENHAGEN - Unprecedented sustained viral response (SVR) rates were achieved in hepatitis C-infected treatment-failure patients, including those with cirrhosis, with telaprevir-based treatment according to PROVE 3 trial results presented today in the late breaker session at the 44th Annual Meeting of the European Asso


Argos Therapeutics Presents Research Validating Feasibility and Safety of its Arcelis(TM) Personalized Immunotherapy Platform for HIV - Abstracts Presented at Canadian Conference on HIV/AIDS Research
Business Wire - April 24, 2009
DURHAM, N.C. - Argos Therapeutics today announced the presentation of two abstracts related to its Arcelis(TM) HIV immunotherapy program at the 18th Annual Canadian Conference on HIV/AIDS Research, held in Vancouver April 23-25th, 2009. These abstracts, presented by Argos collaborators at McGill University Health Centr


Cannabis Compounds Reduce Multi-Drug Resistant Infections - Study Says Cannabinoids Show "Exceptional" Antibacterial Activity Against MRSA
Business Wire - April 23, 2009
SAN FRANCISCO - Cannabis Science, Inc. (OTCBB: GFON). Dr. Robert Melamede, PhD., Director and Chief Science Officer, reported to the Board on the current state of research into the use of natural plant cannabinoids to reduce the spread of drug-resistant bacteria, including methicillin-resistant Staphyloccus aureus (MRS


African First Ladies Summit Ends with Agreement on Leadership, Deployment of Expert Teams to Africa
Business Wire - April 22, 2009
LOS ANGELES - Closing a summit of 14 African first ladies that mixed Hollywood stars and top experts on health policy and development, organizers announced Tuesday, April 21, 2009, that a majority of the women had agreed to strengthened leadership roles in their countries and to work with teams of U.S.-based specialist


New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
Business Wire - April 22, 2009
Vaccine Candidate is the most clinically advanced of a new generation of vaccines under development to combat the TB epidemic OXFORD, England, ROCKVILLE, Md. & CAPE TOWN, South Africa - The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis Consortium Ltd. ( the Consortium ), Isis Innovation Ltd.,


SeraCare Life Sciences Presents Data Supporting the Development of New Diagnostic Control Products at Clinical Virology Symposium -Company Plans to Expand Product Portfolio in 2009
Business Wire - April 22, 2009
MILFORD, Mass. - SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced three presentations at the Clinical Virology Symposium held April 19-22, 2009 in Daytona Beach, FL based on scientific data generated in the Company s research programs. These data support SeraCare s plans to expand their diagnostic controls p


Gilead Sciences Announces Record First Quarter 2009 Financial Results
Business Wire - April 21, 2009
FOSTER CITY, Calif. - Gilead Sciences , Inc. (Nasdaq:GILD) announced today its results of operations for the quarter ended March 31, 2009. Total revenues for the first quarter of 2009 were $1.53 billion, up 22 percent compared to total revenues of $1.26 billion for the first quarter of 2008. Net income attributable to


Be the Buzz of BIO Winners Announced: Contest Allows Innovative Companies to Compete for Visibility at 2009 BIO International Convention
Business Wire - April 21, 2009
WASHINGTON - The Biotechnology Industry Organization (BIO) has announced the four winners of the Be the Buzz of BIO contest – a competition which companies entered in order to win free publicity for their company at the 2009 BIO International Convention by submitting an original video describing why their company and i


Merck Announces First-Quarter 2009 Financial Results
Business Wire - April 21, 2009
WHITEHOUSE STATION, N.J. - Merck & Co. , Inc. today announced financial results for the first quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.74, which excludes $0.07 of restructuring charges and merger- related expenses. First


HELP/PSI Appoints Paul D. Vitale as President and Chief Executive Officer
Business Wire - April 17, 2009
NEW YORK - HELP/PSI Board Chair David S. Ivill announced today the appointment of Paul D. Vitale as President and CEO. In making the announcement at the HELP/PSI Board of Directors meeting, Mr. Ivill remarked, Paul Vitale brings to our organization more than twenty-five years of leadership experience, with particular f


Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV
Business Wire - April 17, 2009
Study Will Assess Safety and Efficacy of Single-Tablet Regimen Containing Elvitegravir Boosted by GS 9350 and Truvada (R) Compared to Atripla(R) FOSTER CITY, Calif. - Gilead Sciences , Inc. (Nasdaq:GILD) today announced that it has begun enrolling patients in a Phase II clinical trial of its investigational integrase


ExxonMobil Supports Upcoming African First Ladies Health Summit
Business Wire - April 16, 2009
-- April 20/21 summit to focus upon women s health and education issues in Africa -- ExxonMobil is an organizing partner of the Summit and the presenting sponsor of the U.S. Doctors for Africa Gala -- ExxonMobil executives to address the summit on key issues relating to women s economic leadership in Africa and HIV/AID


Trimeris Reports First Quarter 2009 FUZEON(R) Sales Results
Business Wire - April 15, 2009
DURHAM, N.C. - Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the first quarter of 2009 were $27.8 million, down 35 percent from $42.7 million in the first quarter of 2008. Net sales of FUZEON in the U.S. and Canada for the first quarter of 2009 were $10.0 million, down 41 percent from


Minnesota HIV Statistics Suggest Need for Greater Education and Focus in Specific Populations
Business Wire - April 15, 2009
MINNEAPOLIS - According to statistics released today by the Minnesota Department of Health, 326 new cases of HIV were reported in Minnesota during 2008. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, noted specific areas of concern including: -- Over 6,200 people are known


ViroStatics Acquires Library of Anti-Cancer/Antiviral Compounds From the University of Siena
Business Wire - April 14, 2009
SASSARI, Italy & PRINCETON, N.J.--ViroStatics srl, a clinical stage biotechnology company developing novel therapeutics for viral and other chronic diseases, announced today that it has obtained an exclusive license to a library of 300 compounds developed by Professor Maurizio Botta (University of Siena) in collabo


VEUVE CLICQUOT Manhattan Polo Classic Returns to Governors Island for the Second Consecutive Year
Business Wire - April 13, 2009
Veuve Clicquot Kicks Off the Summer Season with Polo, the Sport of Kings , and commemorates New York s 400th Anniversary NEW YORK--The Veuve Clicquot Manhattan Polo Classic is returning to New York s historic Governors Island for a second year in a row. The festivities are being held on Saturday, May 30th, in conjuncti


Step Forward in the 22nd Annual Minnesota AIDS Walk to Raise Essential Funding for HIV Education
Business Wire - April 13, 2009
MINNEAPOLIS--The Minnesota AIDS Project is hosting its annual Minnesota AIDS Walk to raise funds and awareness in the ongoing struggle against HIV. On May 17, thousands of concerned Minnesotans will get together at Minnehaha Park in Minneapolis to provide support that the Minnesota AIDS Project needs to maintain critic


Blair Underwood's "Man Up" Ad Campaign Promotes AHF's Free HIV Testing Services
Business Wire - April 10, 2009
Now Appearing on LA Billboards and Online, Campaign Directs Public to www.freeHIVtest.net for Info on Free, Fast and Convenient HIV Testing Locations; Encourages Personal Responsibility and Need for Individuals to Know HIV Status to Protect Partners Campaign is Part of AHF s Year-Long Initiative to Test 40,000 People f


Crofelemer, First-in-Class Anti-Diarrheal Agent, Positive Clinical Results to be Discussed at 13th Annual US-Japan CMSP in Kolkata, India
Business Wire - April 10, 2009
Glenmark Pharmaceuticals Limited Targets Introduction of Crofelemer for 2010 to Address Disease that Kills Millions U.S. - Japan CMSP: 13th International Conference on Emerging Infectious Diseases SOUTH SAN FRANCISCO, Calif. - Napo Pharmaceuticals, Inc., ( Napo ) announces that oral presentations regarding the safety,


Milestone: AHF Now Treating 100,000 Aids Patients Worldwide
Business Wire - April 08, 2009
LOS ANGELES - AIDS Healthcare Foundation (AHF) is proud to announce that, in a major milestone in its mission to provide cutting-edge medicine and advocacy regardless of a person s ability to pay, it has recently surpassed the 100,000 patient mark worldwide. The organization is now providing lifesaving medical care and


Vodafone Americas Foundation Announces Wireless Innovation Project Winners
Business Wire - April 08, 2009
Three Groundbreaking Wireless Innovations for Social Benefit to Share in Prizes Totaling $700,000 to Support Next Phase of Development SAN FRANCISCO, Calif. - The Vodafone Americas Foundation today announced the winners of its Wireless Innovation Project, a new initiative that identifies and funds unique innovations us


CVS's Pattern of Selling Expired Products, Locking Up Condoms Subject of Town Hall Meeting in San Diego, According to Change to Win: Community Advocates, Faith Leaders Reach Out to CVS, Demand Reform of Retail Drugstores
Business Wire - April 07, 2009
SAN DIEGO - CVS s pattern of selling expired products and locking condoms came under fresh scrutiny today at a town hall meeting attended by more than 100 consumer advocates, community activists, and faith leaders who signed a joint letter calling on the nation s largest retail drugstore to reform for the sake of commu


CVS Locking Condoms in East Los Angeles, Communities of Color, according to Change to Win
Business Wire - April 07, 2009
LINCOLN HEIGHTS, Calif. -- CVS drugstores in Los Angeles East side are locking up condoms, a practice that stigmatizes condoms and condom users, according to public health advocates who today announced results of a survey revealing CVS s practice of locking up condoms more often in Latino areas and communities of color


New Statewide Outreach Initiative Joins the Fight Against HIV Infection in Illinois
Business Wire - April 07, 2009
SPRINGFIELD, Ill. -- In an effort to curb a still-serious HIV infection epidemic in Illinois, the Illinois Public Health Association today introduced a new outreach initiative - Illinois HIV Care Connect - to increase awareness about a statewide network of services for HIV-positive individuals. James R. Nelson, executi


Groups Protest Racial, Economic Differences in CVS Health Code Violations, According to Change to Win - Demand CVS unlock condoms in all communities
Business Wire - April 07, 2009
NEW YORK -- Leaders of community organizations criticized racial differences in CVS drugstores health code violations revealed in a new analysis of food-safety inspections at a press conference and rally outside a Harlem CVS today. State inspectors recently cited the CVS on West 125th Street for rodent droppings and a


Aphios Granted Japanese Patent for Inactivating Viruses and Other Pathogens in Biologics and Human Plasma
Business Wire - April 07, 2009
WOBURN, Mass. -- Aphios Corporation today announced that it was granted a Japanese patent for an improved method of inactivating viruses and other pathogens in biologics such as monoclonal antibodies, recombinant therapeutics, human plasma and plasma proteins. The Aphios method is purely physical and does not utilize o


Obama's Domestic AIDS Proposal Disappoints
Business Wire - April 07, 2009
$45M for National HIV/AIDS Awareness Campaign --- Obama s First Official Action on AIDS --- Falls Far Short of Need; Stepped-Up HIV Testing, Linkage to Treatment Will Help Break Chain of Infection US Largest AIDS Group Renews Call on Government to Spend $200M for 10 Million HIV Tests WASHINGTON -- AIDS Healthcare Found


Researchers Uncover Low-Frequency Hepatitis B Drug-Resistant Mutations Using 454 Sequencing Systems
Business Wire - April 07, 2009
Study Results Show Improved Sensitivity for Detecting Low-Prevalence Resistance Variants When Compared to Traditional Methods BRANFORD, Conn. -- A study published online last week in the Journal of Infectious Disease reports that ultra-deep sequencing has the ability to identify low-frequency hepatitis B virus (HBV) dr


Thank You, Arnold, for Saving California AIDS Patients!
Business Wire - April 06, 2009
State Health Officials Reach Compromise on Contract for Renewal of Positive Healthcare Program; Agreement Ensures Lifesaving Primary Care Case Management Plan for Low-income Californians with AIDS Will Continue AHF s Respected 15 Year-old AIDS Care Plan Saved State Nearly $7.5M in Past Five Years SACRAMENTO, Calif. --


World Health Imaging Alliance Poised to Bring Imaging Diagnostics and Data to the Developing World - Not-for-Profit Has a Vision to Help a Billion People
Business Wire - April 06, 2009
CHICAGO -- The World Health Imaging Alliance (WHIA) announced that it has cemented key partnerships that will enable it to significantly ramp up its efforts to bring digital imaging technology to sites in need around the world. Basic diagnostic x-ray services are a key component of primary health care delivery. However


Abstinence-only Programs Hobble PEPFAR
Business Wire - April 06, 2009
President Bush s Landmark Global AIDS Program Cut Deaths in Africa by 10%; However, Country Prevalence Rates Remain Unchanged Due to Focus on Abstinence Over Prevention AHF Calls on President Obama to End PEPFAR s Focus on Abstinence and Step Up Prevention Efforts, Including Widespread Condom Distribution WASHINGTON --


Gilead Sciences Announces Notification of ANDA Filing for Atripla(R)
Business Wire - April 06, 2009
FOSTER CITY, Calif. -- Gilead Sciences , Inc. (Nasdaq:GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration ( FDA ) requesting permission to manufacture and mark


Generations Foursquare Church Hosts World-Renowned Watoto Children's Choir Performance on Wednesday, April 8th at 7 P.M.
Business Wire - April 06, 2009
Children Spread Message of Hope for Ugandan Orphans Through Soulful Fusion of Gospel Music and Contemporary African Dance SAN JOSE, Calif. -- Generations Foursquare Church today announced it will host the world-renowned Watoto ( the children ) Children s Choir from Uganda at a free concert on Wednesday, April 8 from 7


FOX's KCOP-TV Continues Censorship of AHF Condom Ad
Business Wire - April 03, 2009
Before it Will Air Paid Commercial Spot, FOX s KCOP-TV Demands AIDS Group Edit Out Shot of Actress/Activist Sheryl Lee Ralph Holding Up a Wrapped Condom in HIV Testing Public Service Message LOS ANGELES -- AIDS Healthcare Foundation (AHF), which operates the largest community-based alternative HIV and sexually transmit


CVS Selling Expired Products, Locking Condoms in South Florida According to Change to Win - Warning to Consumers Issued by Community Advocates
Business Wire - April 02, 2009
MIAMI -- A delegation of community and faith leaders held a lively demonstration outside a local CVS pharmacy on Thursday to challenge CVS s practice of repeatedly selling products past their expiration dates and locking up condoms, often in communities of color. Activists are reacting to the findings of a study, annou


PHMC Releases Groundbreaking HIV/AIDS Study, Investigates Dangers of "Down Low" Label - Black Men on the Down Low Spread HIV/AIDS at Same Rate as Non-Down Low Men
Business Wire - April 01, 2009
PHILADELPHIA -- Researchers at Public Health Management Corporation (PHMC) published a study in the American Journal of Public Health showing that Black men who have sex with men (MSM) and women and identify themselves as on the down low (DL) engage in the same level of risk with women as behaviorally bisexual men who


South Africa: 1,500 People Celebrate Launch of AHF's New Free AIDS Clinic Location in Umlazi
Business Wire - April 01, 2009
Formal Dedication and Ribbon-cutting Ceremony Marked Move of Ithembalabantu People s Hope AIDS Treatment Clinic Move to New, Larger Freestanding Site at Umlazi s Ithala Centre. AHF Provided Free Mass HIV Testing during Daylong Celebration and Launch DURBAN, South Africa -- Over 1,500 people joined in the dedication and


Institute of Microbiology of the Chinese Academy of Sciences and TB Alliance Announce Partnership to Develop New Tuberculosis Drugs from Natural Sources
Business Wire - March 31, 2009
Announcement precedes three-day ministerial meeting of high MDR-/XDR-TB burden countries in Beijing, April 1-3 BEIJING & NEW YORK -- The Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product d


South Africa: AHF to Launch New State-of-the-Art Free AIDS Treatment Clinic Location in Umlazi
Business Wire - March 31, 2009
After Seven Years of Growth, Ithembalabantu People s Hope AIDS Clinic Moves to New, Larger Freestanding Site at Umlazi s Ithala Centre. Formal Dedication and Ribbon-cutting Ceremony Set for Tuesday, March 31st AHF to Provide Free Mass HIV Testing during Daylong Celebration and Launch with Goal of 500 Tests DURBAN,


AHF to IAS: Return Int'l Aids Conference to U.S. in 2012 - AIDS Healthcare Foundation Offers to Advocate for the Lifting of the U.S. Ban for HIV-Positive Travelers
Business Wire - March 31, 2009
GENEVA - In a meeting last Friday with officials from the International AIDS Society (IAS), a global delegation from AIDS Healthcare Foundation (AHF), the largest AIDS group in the U.S., which currently provides medical care to more than 98,000 individuals in 21 countries worldwide in the U.S., Africa, Latin America/Ca


AHF Lauds 'Lancet' Editorial Criticizing Pope for Distorting Scientific Evidence on Condoms
Business Wire - March 30, 2009
LOS ANGELES -- AIDS Healthcare Foundation (AHF), the US largest non-profit HIV/AIDS organization which currently provides medical care and/or services to more than 98,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today lauded the respected British medical journal, The La


Book and Online Auction Launched to Support Madonna's African Charity
Business Wire - March 30, 2009
NEW YORK -- Madonna s charity Raising Malawi helps to launch the new book I Am Because We Are (PowerHouse Books, $49.95), and an online auction on April 2nd to benefit children in Malawi, a country of only 13 million people, yet home to over 1 million AIDS orphans. I Am Because We Are is a poignant new book of images a


Spaltudaq Corp. Announces Identification of Broadly and Potently Neutralizing Human HIV Antibodies and Change of Company Name to Theraclone Sciences, Inc.
Business Wire - March 30, 2009
SEATTLE -- Theraclone Sciences, a biopharmaceutical company formerly known as Spaltudaq, focused on the discovery and development of human antibodies, announced results from its HIV antibody discovery program at the HIV Immunobiology Meeting of the Keystone Symposia Global Health Series earlier this week. Theraclone ha


1.7M People Visit Webpage Urging Gov. Schwarzenegger to Save California AIDS Care Plan
Business Wire - March 29, 2009
Webpage is Part of Nation s Largest AIDS Organization s Ambitious Public Awareness Campaign to Save AIDS Healthcare Foundation s Positive Healthcare Primary Care Case Management Plan Unless Governor Intervenes by March 31st, Respected Money-Saving AIDS Care Plan Must Cease Operating after 15 years. AHF Has Also Filed a


AHF Meets with WHO & UNAIDS, Urges Swift Action on Access to AIDS Treatment, Testing and Condoms
Business Wire - March 27, 2009
Int l Delegation, Led by New AHF Chief of Global Affairs Jorge Saavedra M.D., Presents Letters Signed By Hundreds of Medical Providers, AIDS Activists Seeking Change in Guidelines to Raise Treatment Initiation Threshold for All and Recommend Full-Course Therapy for All HIV+ Pregnant and Breastfeeding Women GENEVA -- An


AIDS Activists Claim Victory: Abbott Cuts Mexican Price of Kaletra 20%
Business Wire - March 26, 2009
Following Ongoing Coordinated Multinational Protests by Activists, Abbott Drops Price of Key AIDS Drug to $3750.40 MXN from $4688.00 MXN; Advocates Vow to Press Abbott on Kaletra Pricing in Colombia MEXICO CITY - A coalition of AIDS activists known as the Coalicion


Avexa Reaches First Critical Evaluation Point for ATC's Phase III Trial
Business Wire - March 25, 2009
* Last Patient Reaches Week 16 Time Point * On Track for Dose Decision Mid-Year MELBOURNE, Australia - Avexa Limited (ASX:AVX) today announced that the last patient enrolled in the initial two dose phase of the apricitabine (ATC) Phase III trial has passed the week 16 time point. This significant event triggers the sta


18 Million Pound Boost for Discovery of New Oral Treatment for TB - Announcement in Concert with World Tuberculosis Day 2009 - 24 March
Business Wire - March 24, 2009
LONDON - The drive to discover and develop new oral treatments for tuberculosis (TB), which could save millions of lives in developing countries, will receive an 18 million pound boost, International Development Minister Ivan Lewis announced today. Current treatment requires multiple antibiotics to be administered over


Aphios Corporation Executes Collaborative R&D Agreement with VivaCell Biotechnology Espana to Develop Combination Therapy For HIV Latency
Business Wire - March 24, 2009
WOBURN, Mass. - Aphios Corporation today announced entering into a Collaborative Research and Development Agreement with VivaCell Biotechnology Espana S.L., Cordoba, Spain to develop a combination therapy for the treatment of HIV latency. Currently, over 22 million people have died from AIDS and there are over 42 milli


Argos Therapeutics Presents Research on the Development and Evaluation of Immunotherapies for HIV - Abstracts Presented at Keystone Symposia on HIV Immunobiology
Business Wire - March 24, 2009
DURHAM, N.C. - Argos Therapeutics today announced the presentation of an abstract related to its Arcelis(TM) HIV immunotherapy program at the Keystone Symposia Global Health Series conference on HIV Immunobiology, held March 22 - 27 in Keystone, CO. The poster presentation details important research on the immunosuppre


Texas Department of State and Health Services Renews Contract with Ramsell Public Health Rx - Company Provides Cost-Effective Management of Drug Assistance Program
Business Wire - March 23, 2009
OAKLAND, Calif. - Ramsell Public Health Rx, a pharmacy benefit manager and information management company, today announced its contract to provide a pharmacy benefits solution for the Texas Department of State and Health Services HIV State Pharmacy Assistance Program (SPAP) has been renewed. The HIV SPAP is designed to


Coverage Initiated on EpiCept Corp. by KLP Special Situations Report
Business Wire - March 23, 2009
WEST NEW YORK, N.J. - KLP Special Situations Report launched coverage today of EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT), a micro-cap specialty pharmaceutical company. The report analyzes the company s clinical progress, including its recently-approved drug Ceplene for the treatment of Acute Myelogenou


Breakthrough QuantiaMD Series Gives Clinicians Practical Tools to Curb HIV
Business Wire - March 23, 2009
NEWTON, Mass. - Fewer than 5% of clinicians routinely test their patients for HIV, but additional training and modest new resources for physicians could more than double the rate of testing, a critical element in containing the spread of HIV, according to preliminary data collected as part of QuantiaMD s new Expert Pra


Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China
Business Wire - March 20, 2009
Collaboration aims to support the development of innovative healthcare solutions in China that are sustainable, socially responsible, and financially viable NEW YORK - Pfizer Inc and PlaNet Finance announced today that they will team up to conduct an in-depth research project on the healthcare needs of the working poor


Biomagnetics (OTC BMGP) Stem Cell and Biotechnology Developments
Business Wire - March 20, 2009
ORANGEVALE, Calif. - Biomagnetics Diagnostics Corp. (OTC: BMGP) CEO and President Clayton Hardman states, BMGP welcomes the new administration s support of Stem Cell Research, Biotechnology, and Genetic Engineering. Lifting restrictions on federal funding for research on new stem cell lines will have a global impact; w


Florida AIDS Walk Raises $351,500 for HIV/AIDS Services in Florida
Business Wire - March 20, 2009
*100% of Funds Raised by the More Than 2000 Walkers and 175 Teams Goes Toward HIV/AIDS Testing, Prevention, Education, Treatment and Support Services in the State* FT. LAUDERDALE, Fla. - AIDS Healthcare Foundation (AHF) is proud to announce that Florida AIDS Walk 2009 raised $351,500 for HIV/AIDS services in Florida. T


Hyacinth AIDS Foundation Board Appoints New Executive Director
Business Wire - March 18, 2009
NEW BRUNSWICK, N.J. - Hyacinth AIDS Foundation s Board President, Jeri Thomas, announced on March 16 that Kathy Ahearn-O Brien, of Montclair, New Jersey, has been named the Foundation s new executive director, effective immediately. Ms. O Brien succeeds Riki E. Jacobs, who held the position since 1993. Ms. Jacobs, who


Pope's Claim That Condoms Fuel AIDS Epidemic is Misguided, Says AHF
Business Wire - March 17, 2009
LOS ANGELES - AIDS Healthcare Foundation (AHF) today admonished the Pope for his claim that condoms were not a solution to the AIDS epidemic, but were instead part of the problem. In remarks to a group of reporters en route to Africa for Pope Benedict s first official visit to the continent since his elevation to the P


Cytheris Announces Publication of IL-7 HIV Data in The Journal of Clinical Investigation
Business Wire - March 17, 2009
Results of a Phase I/IIa Trial in Lymphopenic HIV-Infected Patients Further Demonstrate the Potential of Interleukin-7 to Induce a Dramatic and Prolonged CD4 and CD8 T Cell Expansion, Which is Sustained for 48 Weeks Outcome Suggests That This Cytokine May Offer the Possibility of a Convenient and Intermittent Adjunct T


Avexa Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC)
Business Wire - March 16, 2009
* No ATC resistance after 96 weeks * Sustained efficacy over two years with strong safety profile * No ATC-related Serious Adverse Events * Week 16 Phase III study results due in second quarter of 2009 MELBOURNE, Australia - Biotechnology company Avexa Limited ( Avexa ) (ASX:AVX) today announced positive data from the


Sunday, March 15th: Actor, Activist Blair Underwood to Join Thousands for Florida AIDS Walk 2009
Business Wire - March 14, 2009
Walk Will Benefit AIDS Healthcare Foundation, AHF Pharmacy, Out of the Closet Thrift Stores, Broward Human Rights Initiative, Gay and Lesbian Community Center of South Florida and The Pet Project As Rate of New Infections in Florida Soars to More Than Sixty Percent Higher than the National Average, Florida AIDS Walk 20


INC Research Appoints Principal Strategist to Infectious Disease Division
Business Wire - March 13, 2009
Sharon L. Benoit Applies HIV and Hepatitis Drug Development Acumen to Leadership Role RALEIGH, N.C. - INC Research (R), Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced the appointment of Sharon Lynn Benoit, BSN, MPH as principal strate


'Stop AIDS in Prison Act' (Waters, D, CA) is 'Urgent Lifesaving Legislation,' says AHF
Business Wire - March 12, 2009
H.R. 1429 Seeks to Address Major Public Health Issue Disproportionately Affecting Minorities and Women with Comprehensive HIV Testing, Treatment and Prevention for Inmates in Federal Prisons WASHINGTON - AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which currently prov


CHI Submits Statement on Follow-On Biologics Legislation
Business Wire - March 11, 2009
LA JOLLA, Calif. - The following statement was issued by California Healthcare Institute (CHI) President and Chief Executive Officer David Gollaher, Ph.D., regarding legislation introduced today by Rep. Henry Waxman (D-CA), Rep. Frank Pallone (D-NJ), Rep. Nathan Deal (R-GA) and Rep. Jo Ann Emerson (R-MO) to establish a


New Proposed Biosimilars Pathway Filled with Potholes, Says BIO: Proposal Jeopardizes Future Medical Breakthroughs
Business Wire - March 11, 2009
WASHINGTON - The following statement was issued by Biotechnology Industry Organization President and CEO Jim Greenwood regarding legislation introduced today by Reps. Henry Waxman (D-CA), Frank Pallone (D-NJ), and Nathan Deal (R-GA) to establish a pathway for the approval of biosimilars: The Biotechnology Industry Orga


Renowned AIDS Activist to Address Biotech's role in HIV/AIDS prevention, treatment 2009 BIO International Convention
Business Wire - March 11, 2009
WASHINGTON - The Biotechnology Industry Organization (BIO) announced today that Sir Elton John will be a keynote speaker at the 2009 BIO International Convention. This year s global event for biotechnology will take place on May 18-21, 2009, at the Georgia World Congress Center in Atlanta. Sir Elton John is schedul


Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Business Wire - March 11, 2009
The Aethlon Hemopurifier(R) Now Proven to Reduce Both HIV and Hepatitis-C (HCV) Viral Load in Human Studies SAN DIEGO - Aethlon Medical, Inc. (OTCBB:AEMD) today announced results of the first-in-man study of the Aethlon Hemopurifier(R) to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune


Stanford Medical Students Want to Help Gay Patients Be Comfortably 'Out' in Doctor's Office
Business Wire - March 10, 2009
STANFORD, Calif. - Every time he goes to a new doctor, Mitchell Lunn faces the question anew: Should he tell his doctor he s gay? The question always comes up, said Lunn, 27, a medical student from North Dakota at the Stanford University School of Medicine. Do I want to come out or not? This hesitancy is common with le


CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety
Business Wire - March 09, 2009
SANTA FE, N.M. - CytoDyn, Inc. (Pink Sheets:CYDY) has sent the FDA what the Company believes is a complete response to the agency s preliminary comments on Cytolin(R), a monoclonal antibody designed to restore immune function in those afflicted with HIV/AIDS. As one example of how this process works, the FDA asked Cyto


Merck and Schering-Plough to Merge
Business Wire - March 09, 2009
Combined Company Positioned for Sustainable Growth Through Scientific Innovation and a Stronger, More Diversified Product Portfolio Powerful Joint R&D Pipeline with Strong Candidates in All Development Phases Doubles the Number of Late-Stage Compounds to 18 Broader Product Portfolio in Critical Therapeutic Areas


New Stanford List of HIV Mutations Vital to Tracking AIDS Epidemic
Business Wire - March 05, 2009
STANFORD, Calif. - In a collaborative study with the World Health Organization and seven other laboratories, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends through


More Than a Virus? AIDS Expert to Talk March 11 at Stanford on What Underlies Epidemic
Business Wire - March 03, 2009
STANFORD, Calif. - AIDS is not just a virus but also a social, economic and political force to be reckoned with. Peter Piot, MD, PhD, one of the world s leading AIDS experts, has long recognized that science alone cannot bring an end to the epidemic. Why AIDS is More than a Virus is the subject of a special event March


Trimeris Reports Financial Results for the Fourth Quarter and Year 2008
Business Wire - March 03, 2009
DURHAM, N.C. - Trimeris, Inc. (Nasdaq: TRMS) today announced financial results for the quarter ended December 31, 2008, reporting net income of $1.5 million, or $0.07 per share compared with $9.1 million, or $0.41 per share for the quarter ended December 31, 2007. This result was primarily driven by decreased FUZEON(R)


New Studies on Pneumococcal Disease in Africa Reinforce Need for Life-Saving Vaccines
Business Wire - March 03, 2009
New Studies on Pneumococcal Disease in Africa Reinforce Need for Life-Saving Vaccines Pneumococcal disease poses highest risk, takes most devastating toll in Africa, yet is preventable with vaccines available now Leading scientific experts applaud South Africa as first African country to introduce vaccine, urge other c


Media Advisory: Lutheran Bishops to be Tested for HIV
Business Wire - March 02, 2009
When: Thursday, March 5, 10 a.m. to 3 p.m. Where: The Lutheran Center, 8765 W. Higgins Rd., Chicago Description: The 67-member Conference of Bishops of the Evangelical Lutheran Church in America (ELCA) agreed last fall to undergo testing for HIV at its March 2009 meeting in Chicago. The purpose is to raise awareness ab


BMS Pulls AIDS Diarrhea Ad Campaign, Says AHF
Business Wire - February 27, 2009
US Largest AIDS Group Blasted Drug Giant With Parody Lampooning Company s Living with HIV Doesn t Mean You Have to Live Here Toilet-themed Ad Campaign; AHF s Parody Added the Headline, We Don t Give a Crap How You Live as Long as You Buy Our Drug! AHF s Paid Print Public Service Announcement Warns Patients about Bristo


HemoBioTech Announces Publication of a Guest Editorial and Two Review Articles on Blood Substitutes by Dr. Jan Simoni - Co-Inventor of HemoTech
Business Wire - February 26, 2009
DALLAS - HemoBioTech (OTCBB:HMBT) (www.hemobiotech.com) announced today the publication of a guest editorial and two review articles by Dr. Jan Simoni on blood substitutes in the Journal of Artificial Organs (Vol. 33, No. 2, 2009). The editorial entitled: Artificial Oxygen Carriers: Scientific and Biotechnological Poin


Aethlon Medical Announces Cytomegalovirus (CMV) Research Program
Business Wire - February 26, 2009
SAN DIEGO - Aethlon Medical, Inc. (OTCBB:AEMD) announced today it has initiated a research program to test the capabilities of the Aethlon Hemopurifier(R) to identify and capture Cytomegalovirus ( CMV ). The Hemopurifier(R) is a first-in-class medical device that assists the immune response in combating infectious dise


Bioject Enters into a Collaborative Research Agreement with IAVI for the Delivery of an HIV Vaccine Candidate
Business Wire - February 24, 2009
PORTLAND, Ore. - Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, today announced that it has entered into an agreement with the International AIDS Vaccine Initiative (IAVI) to supply its unique Needle-Free Injection Therapy (NFIT) system, the Biojector(R) 2


AHF Launches Innovative, Eye-Catching "Stay Negative" HIV Testing Campaign
Business Wire - February 23, 2009
Now Appearing on Los Angeles Billboards and Online, AHF s Testing Initiative Features Striking Image of Semi-Nude Male with Stay Negative Tattooed on His Back, Directs Viewers to www.FreeHIVTest.net for Info on Free, Fast and Convenient HIV Testing Locations Campaign is Part of AHF s Year-Long Initiative to Test 40,000


Panacos Provides Corporate and Strategic Update
Business Wire - February 23, 2009
WATERTOWN, Mass. - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), today announced it has engaged Oppenheimer & Co. Inc. to advise the Company on strategic alternatives, which may include the sale of Panacos or its HIV development programs. In addition, the Company will close its Gaithersburg facility and reduce its


Revolutions Medical Receives 510K FDA Clearance to Market Rev Vac Safety Syringe
Business Wire - February 19, 2009
MOUNT PLEASANT, S.C. -- Revolutions Medical Corporation (OTCBB: RMCP) has received notification from the FDA that the 510K application for the Rev Vac safety syringe is approved. This represents a major step forward for the company towards realizing its goal in becoming a major player in the safety syringe market.


New CDC HIV Report Presents Unclear Picture, but Suggests Names Reporting, Testing are Working
Business Wire - February 19, 2009
Agency Releases 2007 HIV/AIDS Surveillance Report; Cites New HIV Reporting Regulations in States and Increased Testing as Reasons for Increase in HIV Numbers AHF Awaits White House Appointment of CDC, HHS and Other Health Leaders; Will Press Government Officials for Stepped-up Response to Nation s Epidemic WASHINGTON -


AHF Sues California Over Forced Closure of AIDS Care Plan; Retaliation by Health Officials
Business Wire - February 19, 2009
Nation s Largest AIDS Organization Files Suit Against State s Department of Health Care Services (DHCS); Asserts Punitive Action by State is Forcing AHF s Respected, Money Saving Positive Healthcare AIDS Primary Care Case Management Plan to Cease Operating After 15 Years


A 454 Sequencing Study Reveals New Insights in Drug Resistance and Tropism Associated with the New HIV Integrase and Entry Inhibitor Therapy Classes: Research study results may have potential implications for therapy selection in HIV patients in the future
Business Wire - February 18, 2009
BRANFORD, Conn. & MONTREAL -- New data from two studies, presented last week at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal, Canada demonstrate that ultra-deep sequencing with the Genome Sequencer FLX System from 454 Life Sciences, in combination with traditional methods, may


VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors: DNA Vaccine Developer Provides Clinical Update on PENNVAX(TM) HIV Vaccines Programs
Business Wire - February 18, 2009
BLUE BELL, Pa. -- VGX Pharmaceuticals Inc. (VGX), a leading developer of DNA vaccines and therapies for HIV infection, announced today that its collaborators from the University of Pennsylvania presented data showing enhanced magnitude and quality of immune responses induced by VGX s DNA vaccines with electroporation d


Aethlon Medical Announces Completion of 30-Day Hepatitis-C Treatment Study
Business Wire - February 18, 2009
SAN DIEGO -- Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has completed a 30-day treatment case study to further evaluate the safety and efficacy of the Aethlon Hemopurifier(R) as a candidate treatment for Hepatitis-C Virus (HCV) infection. The Hemopurifier(R) is a first-in-class medical device that assis


454 Sequencing Identifies Early Stage HIV Drug Resistance-- Low-level Mutations may have Significant Impact on Clinical Outcomes
Business Wire - February 17, 2009
Retrospective Research Study Shows That Even the Lowest Levels of Resistance Mutations Could Lead to Early Treatment Failure BRANFORD, Conn -- A research study published online this week in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a


Bristol-Myers Squibb Foundation Announces Funding of More Than $1.17 Million to Bridge Gaps in Hepatitis C Awareness, Prevention and Care in China, India and Taiwan
Business Wire - February 13, 2009
PRINCETON, N.J. -- The Bristol-Myers Squibb Foundation today announced funding of more than $1.17 million, focused on hepatitis C prevention and education and the mitigation of the disease in China , India , and Taiwan .


LabCorp is the First National Commercial Lab to Offer Roche's COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HCV Test
Business Wire - February 12, 2009
BURLINGTON, N.C. -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HCV Test. This assay is intended to be used as an aid in managin


FOX Rejects PG-rated AHF Condom Ad during Raunchy 'Family Guy': LA FOX Affiliate Censors Heartfelt Public Health Message featuring Actress/Activist Sheryl Lee Ralph from Broadcast on Network's Popular Prime Time Off-color Cartoon Sitcom
Business Wire - February 12, 2009
AHF to Continue with Planned Condom Campaign; Group Will Distribute 20,000 Free Valentine s Day-themed LOVE Condoms via its LOVE Condom Mobile Along West Hollywood s Sunset Strip Friday Night LOS ANGELES -- AIDS Healthcare Foundation (AHF): What: Press Conference & Teleconference LA FOX Affiliate Bans Condom Ad fro


CVS/pharmacy Challenged by Public Health Advocates, Community Leaders to Free the Condoms, Reports CtW
Business Wire - February 12, 2009
WASHINGTON -- Public health advocates challenged CVS/pharmacy today over its policy of keeping condoms in locked cases in CVS stores located in communities of color, which are disproportionately affected by HIV and AIDS. A recent survey of CVS stores by Change to Win showed that in a number of cities across the country


OraSure Announces Fourth Quarter and Full Year 2008 Financial Results
Business Wire - February 11, 2009
BETHLEHEM, Pa. -- OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $71.1 million and $17.2 million for the year and quarter ended December 31, 2008, respectively. This compares to revenues of $82.7 million and $19.8 million for the year and quarter ended D


Aethlon Medical Announces Expansion Into the Infectious Disease Diagnostic Market
Business Wire - February 10, 2009
SAN DIEGO -- Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has expanded the applications of its Hemopurifier(R) platform technology to address voids in the infectious disease diagnostic market. The Aethlon Hemopurifier(R) is a first-in-class artificial adjunct to the immune system able to provide real-time


Hasbro, Inc. Launches PROJECT ZAMBI to Provide Hope, Care and Comfort for Children Orphaned by AIDS in Africa
Business Wire - February 10, 2009
PAWTUCKET, R.I. -- Hasbro, Inc. (NYSE:HAS) announces the launch of PROJECT ZAMBI, a global cause initiative dedicated to raising awareness and supporting programs that help care for the estimated 15 million children who have been orphaned as a result of the AIDS epidemic in Africa. This latest initiative, which was emp


Progenics Selects Subcutaneous Form of PRO 140, a Novel HIV Antibody Therapy, for Further Development -- Positive Phase 2 Clinical Results Showed PRO 140 Demonstrated Potent Activity, Favorable Tolerability and the Convenience of Potential Weekly Self-Administration
Business Wire - February 10, 2009
MONTREAL & TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that it has selected for further development the subcutaneous form of PRO 140 for the treatment of HIV infection. The decision follows positive results from a recently completed phase 2 clinical trial as well as feedback fr


Research and Markets: Good Prospects of Finding a Cure for HIV/AIDS in The Next Decade Reveals Report
Business Wire - February 10, 2009
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/606ba8/antiviral_ther apeu) has announced the addition of Jain PharmaBiotech s new report Antiviral Therapeutics - Technologies, Markets and Companies to their offering. This report reviews the current state-of-art of antiviral app


AHF's World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+
Business Wire - February 10, 2009
Ambitious World AIDS Day Campaign Led by AIDS Healthcare Foundation Far Surpasses Goal of One Million Tests; Shatters Myths about Streamlined Testing & Counseling Models LOS ANGELES -- A groundbreaking global effort led by AIDS Healthcare Foundation (AHF) to test one million people for HIV as part of a global testi


Phase III Studies Showed ISENTRESS(R) in Combination Therapy Provided Significant Viral Load Reductions through 96 Weeks in Treatment-Experienced Patients with Triple-Class Resistant HIV
Business Wire - February 09, 2009
MONTREAL -- In new subgroup analyses of a Phase III study (STARTMRK) that compared Merck & Co. , Inc. s integrase inhibitor ISENTRESS(R) (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated (treatment-naïve) HIV-infected patients], ISENTRESS was found to be as effective


Data from ISENTRESS(R), Merck's HIV Integrase Inhibitor, in Patients Whose HIV is Controlled on a Lopinavir/Ritonavir-Based Therapy Presented at the 16th Conference on Retroviruses and Opportunistic Infections
Business Wire - February 09, 2009
Two Phase III studies (SWITCHMRK-1 and -2) evaluating the effect of switching patients whose HIV is controlled on a lopinavir /ritonavir-based regimen to a regimen containing Merck & Co. , Inc. s HIV integrase inhibitor ISENTRESS(R) (raltegravir) tablets showed that ISENTRESS significantly improved total cholestero


Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System: Web-based System Streamlines Program Administration and Provides States With Complete Control
Business Wire - February 09, 2009
OAKLAND, Calif. -- Ramsell Public Health Rx, a pharmacy benefit manager and information management company, today announced the availability of the AIDS Drug Assistance Program (ADAP) Data Management System, a highly configurable, web-based system designed to assist with program administration and compliance while prov


Gilead Announces Data Demonstrating Pharmacokinetic Boosting Activity of GS 9350: Phase I Data Support Development of a Fixed-Dose Combination Regimen Containing GS 9350, Elvitegravir and Truvada(R) for the Treatment of HIV/AIDS
Business Wire - February 09, 2009
MONTREAL -- Gilead Sciences , Inc. (Nasdaq: GILD) today announced preclinical data and results from two Phase I studies for GS 9350, an investigational compound being developed as a pharmacoenhancing agent ( booster ) to increase blood levels and allow once-daily dosing for certain medicines, including Gilead s investi


Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI)
Business Wire - February 06, 2009
PARIS -- Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announces the presentation of its results on a new quinoline family acting as HIV integrase inhibitors at the 16th Conference on Retroviruses and Oppo


Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc.
Business Wire - February 05, 2009
NEW YORK -- Standard & Poor s announced today that it has commenced Factual Stock Report coverage on GeoVax Labs, Inc. GeoVax Labs, Inc. (BB:GOVX), is a biotechnology company developing human vaccines for diseases caused by HIV-1 and other infectious agents. GeoVax seeks to develop, manufacture, license and commerc


March 15th: Actor, Activist Blair Underwood to Join Thousands for Florida AIDS Walk 2009: Walk Will Benefit AIDS Healthcare Foundation, Broward Human Rights Initiative, Gay and Lesbian Community Center of South Florida and The Pet Project
Business Wire - February 05, 2009
As Rate of New Infections in Florida Soars to More Than Sixty Percent Higher than the National Average, Florida AIDS Walk 2009 Will Raise Funds and Highlight Need for Increased Prevention, Education and Testing Efforts in the State FT. LAUDERDALE, Fla. -- AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday


Research and Markets: Iran Pharmaceuticals and Healthcare Report Q1 2009 - In the Past Five Years Iran's Authorities Spent Around US$20mn on HIV/AIDS Control and Education
Business Wire - February 04, 2009
DUBLIN, Ireland -- Research and Markets(http://www.researchandmarkets.com/research/7dda94/iran_ph armaceutica) has announced the addition of the Iran Pharmaceuticals and Healthcare Report Q1 2009 report to their offering. This Iran Pharmaceuticals and Healthcare Report provides independent


Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material
Business Wire - February 04, 2009
ROCKVILLE, Md. -- Omnia Biologics, Inc. (Rockville, MD) and Sumagen Co., Ltd. (London, ON) today jointly announced the successful completion of cGMP manufacture of Sumagen s HIV/AIDS vaccine for a Phase I clinical trial. Safe, effective vaccines for HIV prophylaxis and therapy remain a vital and elusive goal in the fig


Trimeris Reports Fourth Quarter 2008 FUZEON(R) Sales Results
Business Wire - February 03, 2009
DURHAM, N.C. -- Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the fourth quarter of 2008 were $40.5 million, down 39 percent from $66.5 million in the fourth quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the fourth quarter of 2008 were $16.1 million, down 49 percent f


Research and Markets: Global HIV Market: New Analysis Discusses the Opportunities Prevailing in the HIV Drugs Market and Issues Affecting the Growth
Business Wire - February 03, 2009
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/5eee2e/global_hiv_mar ket) has announced the addition of the Global HIV Market: An Analysis report to their offering. HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment fo


Merck Announces Fourth-Quarter and Full-Year 2008 Financial Results
Business Wire - February 3, 2009
WHITEHOUSE STATION, N.J. -- Merck & Co. , Inc: The Company reported fourth-quarter 2008 non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.87, which excludes restructuring charges of $0.09. Fourth-quarter GAAP EPS was $0.78. Merck also announced full-year 2008 non-GAAP EPS of $3.42,


Aethlon Medical Provides Clinical Update at International Conference on Dialysis
Business Wire - February 3, 2009
SAN DIEGO -- Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chief Science Officer, Dr. Richard H. Tullis presented a clinical report on the Aethlon Hemopurifier(R) to Nephrologists attending the International Conference on Dialysis on January 29th. The focal point of Dr. Tullis s presentation was the use o


Napo Pharmaceuticals Receives Cornerstone Investment for Crofelemer Access Program: Crofelemer, Once Approved for Children, Could Aid in Treating Diarrhoel Diseases That Kill An Estimated 2.5 million Children Each Year
Business Wire - February 3, 2009
SOUTH SAN FRANCISCO, Calif. -- Napo Pharmaceuticals, Inc., ( Napo ) of South San Francisco, California, whose novel anti-diarrheal compound crofelemer is currently in late-stage clinical development has received an initial cornerstone investment in a wholly owned subsidiary, Crofelemer Access Program ( CAP ) Global LLC


AHF: Senate Democrats Allow HIV Testing To Be Stripped From Stimulus: Decision Will Mean Loss of Needed Healthcare Jobs, Increase in HIV Infections and Medical Costs
Business Wire - February 2, 2009
Senate Bill Called for $400M for HIV and STD Testing and Prevention; Money Would Go to Hire RNs for HIV Testing in Emergency Units and Community Clinics and Pay for American-made Test Kits WASHINGTON -- AIDS Healthcare Foundation (AHF), the nation s largest AIDS organization, expressed its disappointment that Senate De


Americans Come Together to Fight Global Poverty and Honor International Women's Day at A POWERFUL NOISE Live! – a One-Night Big Screen Event on March 5th
Business Wire - February 2, 2009
Christy Turlington Burns, Nicholas Kristof, Dr. Helene Gayle Join Other Humanitarians During Exclusive LIVE In-Theatre Event in More Than 450 Select Movie Theatres A POWERFUL NOISE Live! Presented by National CineMedia s (NCM) Fathom and CARE, in Partnership with ONE and the UN Commission on the Status of Women ATLANT


Gilead Announces Senior Management Promotion
Business Wire - February 2, 2009
FOSTER CITY, Calif. - Gilead Sciences , Inc. (Nasdaq:GILD) today announced the promotion of Andrew Cheng, MD, PhD to the newly created role of Senior Vice President, Development Operations. In this role, Dr. Cheng will be responsible for Gilead s biometrics, clinical operations, drug safety and public health, project a


Diagnostic HYBRIDS and Case Western Reserve University Announce Licensing Agreement for the Development of an HIV Tropism and Drug Resistance Platform
Business Wire - February 2, 2009
ATHENS, Ohio -- Diagnostic HYBRIDS and Case Western Reserve University have signed an exclusive worldwide licensing agreement granting Diagnostic HYBRIDS rights to a novel yeast-based virus cloning technology invented by noted Human Immunodeficiency Virus (HIV) researcher Eric Arts, Ph.D., Associate Professor of Medici


Progen-Avexa Merger Update
Business Wire - January 30, 2009
* Progen reiterates support for merger with Avexa and updates indicative timeframe * Proposed off-market buy back gives Progen shareholders a cash option at $1.101 * Progen board highlights the uncertainty over alternative options to the merger and the timing and quantum of funds that may be realised via a capital retu


World Economic Forum Gives Adolescent Girls a Voice on the Global Stage
Business Wire - January 30, 2009
--Corporate, Foundation, Government and NGO Leaders to Discuss Girls Ability to End Intergenerational Cycles of Poverty DAVOS, Switzerland--With an agenda focused almost exclusively on the global financial crisis, the World Economic Forum s Annual Meeting program today will feature its first-ever plenary session focuse


AHF Applauds Senator Harkin for Championing HIV Testing in Stimulus Bill
Business Wire - January 29, 2009
-- Senate Bill Calls for $400M for HIV and STD Testing and Prevention; Money Could Go to Hire RNs for HIV Testing in Emergency Units and Community Clinics and Pay for American-Made Test Kits Delegation of Florida AIDS Patients and RNs from AIDS Healthcare Foundation Had Called for $300M for HIV Testing During 55 Senate


AHF: Abbott Censors AIDS Activists on YouTube? AHF's 60 Second Video Parody Blasting Abbott Laboratories Inc. Was Mysteriously Removed From YouTube After 36 Hours and 902 views
Business Wire - January 29, 2009
--Video-and Protest Actions This Week in Mexico , Colombia and the US-Slam Abbott For High Prices That Keeps Its Lifesaving AIDS Drugs Out of Reach for People Living with HIV/AIDS Around the Globe LOS ANGELES--A video parody criticizing Abbott Laboratories


Zacks Bull & Bear of the Day Highlights: VistaPrint, Trimeris, Newmont Mining, Kinross Gold and Gilead Sciences
Business Wire - January 29, 2009
CHICAGO--Zacks Equity Research picks VistaPrint Limited (Nasdaq: VPRT) as Bull of the Day and Trimeris, Inc. (Nasdaq: TRMS) as Bear of the Day. In addition, the analysts at Zacks Equity Research discuss the latest on Newmont Mining (NYSE: NEM), Kinross Gold Corp. (NYSE: KGC) and Gilead Sciences , Inc. (Nasdaq: GILD)


Photo of AIDS Healthcare Foundation Advocates and Chicago-Area Activists Protesting Abbott Laboratories' AIDS Drug Prices in Mexico and Colombia is Available on Business Wire's Web Site and AP PhotoExpress
Business Wire - January 28, 2009
CHICAGO -- AIDS Healthcare Foundation advocates, joined by Chicago-area medical student activists and the Chicago Women s AIDS Project, protested today outside the Lake Forest, IL home of Abbott Laboratories CEO Miles D. White over the company s AIDS drug prices in Mexico and Co


Orlando-based Health Initiative Wins National Award for HIV Prevention and Continuum of Care to Individuals
Business Wire - January 28, 2009
-- Orlando Health Help Understand and Guide Me (HUG-Me) Program Selected as 2009 Monroe E. Trout Premier Cares Award Winner PHOENIX--Orlando Health has been honored by the Premier healthcare alliance with the 17th Annual Monroe E. Trout Premier Cares Award for its Help Understand and Guide Me (HUG-Me) program, which pr


Join the Twin Cities Oscar Night(R) America Party to Benefit the Minnesota AIDS Project
Business Wire - January 28, 2009
MINNEAPOLIS--The excitement and glamour of Hollywood are coming to Minneapolis on Oscar Night. Twin Cities residents can experience the thrills and surprises of the 81st Academy Awards(R) on Sunday, February 22, 2009, at Minnesota s own Oscar Night America party. The Minnesota AIDS Project Oscar Night Minnesota event i


U.S. FDA Approves OraQuick ADVANCE(R) 12-Month Shelf Life Dating
Business Wire - January 28, 2009
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that the United States Food and Drug Administration ( FDA ) has approved its request for 12-month shelf life from the date of manufacture for its OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test. The FDA approval is based on enhancements made b


Abbott Drug Pricing Condemned by AIDS Advocates in International Protests
Business Wire - January 27, 2009
-- In Coordinated Actions Wednesday, Protesters in Mexico, Colombia and the US Demand that Abbott Lowers the Price of Its Key AIDS Drug Kaletra ; Advocates Otherwise Vow to Seek Compulsory Licenses in Colombia and Mexico In US, AHF to Also Premiere 60 Second Video P


Gilead Outlines R&D Priorities for 2009
Business Wire - January 27, 2009
- Progress in Clinical Development Highlighted in Fourth Quarter and Year End Financial Results Conference Call - FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq:GILD) today highlighted the company s clinical development priorities for 2009 as part of its fourth quarter and year end 2008 financial results conferen


AHF Welcomes Mexico's Dr. Jorge Saavedra as Its New Chief of Global Affairs
Business Wire - January 27, 2009
-- Internationally-Recognized for His Accomplishments as the Head of Mexico s National HIV/AIDS Program and for His Successful Advocacy Work, Dr. Saavedra Will Oversee AHF s Global Medical Care, Prevention and Advocacy Programs in Twenty Countries in Africa, Latin America/Caribbean and Asia LOS ANGELES--AIDS Healthcare


Whole Foods Market Joins the Minnesota AIDS Project to Support HIV Prevention
Business Wire - January 27, 2009
MINNEAPOLIS--Whole Foods Market in Minneapolis and St. Paul are joining with the Minnesota AIDS Project to raise awareness of and funds for HIV prevention and services in Minnesota by hosting 5 Percent Day on February 11, 2009. The program will feature educational information about the Minnesota AIDS Project in-store a


Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
Business Wire - January 27, 2009
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY): * Key Franchises and Products Drive Solid Top-Line Growth * Financial Results Supported by Significant Improvement in Gross Profit and Improved Cost Management Driven Largely By Productivity Initiatives * Provides 2009 GAAP EPS Guidance Range of $1.58


Aethlon Medical Completes First Medical Device Study to Treat HIV/AIDS
Business Wire - January 26, 2009
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has completed the first-in-man study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, an HIV-infected individual completed a twelve treatment study of t


IAVI and Algonomics to Collaborate on HIV Protein Design Project
Business Wire - January 26, 2009
-- IAVI s Innovation Fund to support novel approach to improve immunogenicity of AIDS vaccine candidates GENT, Belgium & NEW YORK--The International AIDS Vaccine Initiative (IAVI) and Algonomics today announced a collaboration to modify an HIV protein in order to improve immune responses elicited by HIV vaccine can


Obama Lifts Global Funding Ban, Unties Hands of HIV/AIDS Groups, Says AHF
Business Wire - January 23, 2009
WASHINGTON--AIDS Healthcare Foundation (AHF) today lauded President Barack Obama for lifting a ban on federal funds for international groups that perform abortions or provide information or counseling on the option. According to the Associated Press, The policy bans U.S. taxpayer money, usually in the form of U.S. Agen


VIRxSYS to Present at Phacilitate Cell & Gene Therapy Forum
Business Wire - January 22, 2009
VIRxSYS WHAT: VIRxSYS to present data on its first clinical trial using lentiviral vectors in a presentation entitled Findings from Phase I/II and decisions regarding next step. The presentation will address the following: -- Successful delivery of a 937 base antisense sequence to HIV envelope -- Cumulative data on pat


Converse (PRODUCT) RED(TM) Introduces Spring 2009 1HUND(RED) Artists Collections Featuring New Creative from Internationally Celebrated Musicians, Artists and Designers
Business Wire - January 22, 2009
-- Converse s Unprecedented Global Curation Project Includes New Limited Edition Designed Shoes In Support of Converse (PRODUCT) RED NORTH ANDOVER, Mass.--Converse debuts an exciting new collection of designs for Spring 2009 in its final installment of 1HUND(RED) Artists footwear, the brand s unprecedented global curat


Red Ribbon Charitable Foundation to Support AHF's HIV/AIDS Services in Rural Florida
Business Wire - January 22, 2009
-- Generous Grant Will Fund Mobile Health Unit Operations, Filling Crucial Need for HIV/AIDS Prevention, Testing and Medical Services in Escambia, Okaloosa, Santa Rosa & Walton Counties FT. LAUDERDALE, Fla.--AIDS Healthcare Foundation (AHF), operator of Positive Healthcare Florida, is pleased to announce it has rec


Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics
Business Wire - January 21, 2009
SAN MARINO, Calif.--Dr. Leslie Z. Benet, an internationally recognized drug development expert and one of the most highly cited pharmacologists in the world, has joined the advisors of Viral Genetics. CEO, Viral Genetics, Haig Keledjian said: To have an advisor of Dr. Leslie Benet s stature in drug development join our


The Royal Government of Cambodia Awards the 'Royal Order of Sahametrei' to Dr. Chinkholal Thangsing
Business Wire - January 21, 2009
-- AIDS Healthcare Foundation Physician and Treatment Advocate Honored for Service to People Living with HIV/AIDS in Cambodia , Where AHF Now Operates 11 Free Treatment Clinics PHNOM PENH, Cambodia--The Royal Government of Cambodia has awarded its prestigious Royal Order of Sahametrei to Dr. Chinkholal Thangsing, Asia


Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics
Business Wire - January 21, 2009
SAN MARINO, Calif.--Dr. Leslie Z. Benet, an internationally recognized drug development expert and one of the most highly cited pharmacologists in the world, has joined the advisors of Viral Genetics. CEO, Viral Genetics, Haig Keledjian said: To have an advisor of Dr. Leslie Benet s stature in drug development join our


Panacos Announces Sale of Bevirimat
Business Wire - January 21, 2009
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Myriad Pharmaceuticals, Inc. has acquired Panacos rights and assets with respect to its bevirimat compound for $7.0 million. The acq


House Adopts AHF Stimulus Funding Proposal for HIV Testing and Prevention
Business Wire - January 16, 2009
-- House Includes $355M for CDC for HIV/AIDS and STD Services in Stimulus Bill; Delegation of AHF Nurses and AIDS Patients from Florida Sought $300M in Stimulus Package for HIV Testing throughout Hard-hit Southern US During 55 Senate and Congressional Visits this Week WASHINGTON--AIDS Healthcare Foundation (AHF) lauded


Aussie Jessie Sparks Becomes a MAC Girl: Melbourne Australia's Singer-Songwriter Honored With Endorsement From MAC Cosmetics
Business Wire - January 16, 2009
LOS ANGELES--Since winning a Hollywood Music Award for Best Adult Contemporary Artist , Melbourne Australia s singer-songwriter Jessie Sparks (www.JessieSparks.com) career has been in high drive. MAC Cosmetics (www.maccosmetics.com) has officially signed-on to endorse Sparks. Being a huge fan of their products and thei


Asia Society Task Force Provides New Model for Deeper Private and NGO Sector Involvement in Strategic US-India Partnerships
Business Wire - January 16, 2009
NEW YORK--A new Asia Society Task Force outlines a bold strategy for the incoming US administration to enhance collaboration with India on global challenges ranging from security and economic growth to climate change, education, agriculture and HIV/AIDS. As the recent attacks in Mumbai made clear, there is urgent need


Monogram Announces Record Revenue for 2008, Guidance for Revenue Growth in 2009 and Plan for Achieving Sustainable Positive Cash Flow
Business Wire - January 15, 2009
-- Monogram Regains Compliance with Nasdaq Listing Requirements SOUTH SAN FRANCISCO, Calif.--Monogram Biosciences, Inc. (Nasdaq:MGRM) announced that it expects to report revenues of approximately $62 million for the year ended December 31, 2008, an increase of 44% over the prior year. The company established 2009 reven


Room & Board Announces Two-Year Grant of $50,000 and Employee Time to Chicago House
Business Wire - January 15, 2009
MINNEAPOLIS--Room & Board, the Minneapolis-based furniture retailer offering unique home furnishings that combine classic, simple design and exceptional quality, today announced a two-year gift totaling $50,000 and employee volunteer time to Chicago House, the first organization in the Midwest to provide housing an


Aethlon Medical Nears Completion of First Medical Device Study to Treat HIV/AIDS
Business Wire - January 15, 2009
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it is nearing completion of the first-in-man study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, an HIV-infected individual recently initiated treatmen


Immuron's BioGard HIV Antibody Into A U.S. Clinical Trial
Business Wire - January 15, 2009
-- Immuron Ltd. Announces Phase II trial of BioGard in U.S., its oral adjunctive -HIV therapy; wins research grant for an HIV antibody SAN FRANCISCO & MELBOURNE, Australia--Immuron Ltd. (ASX: IMC), a biopharmaceutical company specializing in oral immunotherapy development and antibody manufacturing, announced today


STD Rates: New Administration Must Revamp Prevention and Promote Safer Sex, Condom Usage, Says AHF
Business Wire - January 14, 2009
-- Latest CDC Report Shows Rates of Gonorrhea, Syphilis and Chlamydia Rise Dramatically in Youth and Minority Populations; Incoming CDC Director Must Overhaul Failed Prevention Policies LOS ANGELES--Alarming new statistics from the Centers for Disease Control (CDC) regarding sexually transmitted disease rates in the US


Research and Markets: "Competitor Analysis: Anti-Infective Peptides" Provides A Competitor Evaluation In The Field Of R&D Projects
Business Wire - January 14, 2009
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/6558e4/competitor_ana lysi) has announced the addition of the Competitor Analysis: Anti-Infective Peptides report to their offering. The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral


'Intent to Award' Florida Medicaid HIV/AIDS Disease Management Program Notice Goes to AHF's Positive Healthcare
Business Wire - January 13, 2009
-- Following Competitive Bid Process, Incumbent Provider AHF Receives Notice from Florida s Agency for Health Care Administration (AHCA RFP 0901) Allowing for Continuation of HIV/AIDS Disease Management Services FT. LAUDERDALE, Fla.--Following a competitive bid process among three potential finalists, Florida s Agency


Aethlon Medical to Present at 11th International Conference on Dialysis
Business Wire - January 13, 2009
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis will give a clinical presentation of the Aethlon Hemopurifier(R) at the 11th International Conference on Dialysis on January 29th. The presentation will review treatment outcomes of dialysis patients infe


Stimulus: Florida AIDS Patients, RNs Lobby Congress for Funding for HIV Testing
Business Wire - January 12, 2009
-- During 55 Senate and Congressional Visits This Week, AIDS Healthcare Foundation Delegation Seeks Funding for HIV Testing in Hard-hit Southern US; Region Reports 36% of Nation s AIDS Cases WASHINGTON--As the HIV/AIDS epidemic continues to have a disproportionate—and devastating—impact throughout the Southern


Ardea Biosciences Announces Positive Results from a Phase 1 Study of RDEA594
Business Wire - January 12, 2009
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) today announced positive results from a completed single ascending dose (SAD) Phase 1 clinical study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. The study was conducted in normal healthy volunteers with serum uric acid above 5.0 mg


Vertex Outlines 2009 Business Priorities: Registration Programs in Hepatitis C and Cystic Fibrosis; Balanced Investment to Maintain Financial Strength
Business Wire - January 12, 2009
- Broad telaprevir registration program for treatment-naive and treatment-failure HCV patients nears enrollment completion - - Vertex expects to initiate VX-770 registration program in cystic fibrosis - - Vertex ends 2008 with approximately $830 million in cash, cash equivalents & marketable securities - SAN FRANCI


AHF: Just Say "No!" to Flynt's Porn Industry Bailout Request
Business Wire - January 11, 2009
LOS ANGELES--Larry Flynt is asking the taxpayers of this country to pay for his reckless, greed driven sexual exploitation of his actors and by extension, the public s lives. Flynt, the Porn King of America, is Public Health Enemy Number One regarding HIV/AIDS. Flynt s outrageous request for a government bailout for th


Company Receives Grant to Further Develop Disease-Fighting Technology
Business Wire - January 9, 2009
WEST LAFAYETTE, Ind.--Kylin Therapeutics announces plans to further develop a Purdue University technology that could allow physicians to target drug delivery for treatment of diseases ranging from AIDS to cancer. The life sciences firm received a $1.2 million grant from the State of Indiana s 21st Century Research and


Bono to Write New York Times Op-Ed Column: First in a Series of Occasional Op-Eds Will Appear on Sunday
Business Wire - January 9, 2009
NEW YORK -- The New York Times announced today that Bono, the U2 lead singer and anti-poverty activist, has been invited to write a column for The New York Times. Beginning this Sunday, his columns will appear occasionally on The New York Times Op-Ed page and online at nytimes.com/opinion and will cover a broad range o


Learn about the World HIV/AIDS Testing Market
Business Wire - January 8, 2009
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Diagnostic equipment industry is available in its catalogue. World HIV/AIDS Testing Market http://www.reportlinker.com/p098402/World-HIV/AIDS-Testing--Marke t.html This report analyzes the worldwide markets for HIV/AI


Research and Markets: South Africa Pharmaceuticals and Healthcare Report Q4 2008 - Between 2008 and 2012, it is Forecasted that the Average Drug Expenditure Growth will be 10.3% a Year
Business Wire - January 5, 2009
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/d7bb7c/south_africa_pharm) has announced the addition of the South Africa Pharmaceuticals and Healthcare Report Q4 2008 report to their offering. South Africa Pharmaceuticals and Healthcare Report provides independent forecasts and compet


OraSure Technologies to Participate at the Eleventh Annual Needham Growth Conference
Business Wire - January 5, 2009
-- Needham Growth Stock Conference 2009 BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Eleventh Annual Needham Growth Conference in New York at approximately 10:30 am Eastern Time (7:3


Avexa and Progen Merger Update
Business Wire - January 5, 2009
-- Investor Forums to Be Held in Sydney, Brisbane and Melbourne MELBOURNE, Australia--Biotechnology companies Avexa Limited (ASX:AVX) and Progen Pharmaceuticals Limited (ASX:PGL) (NASDAQ:PGLA) announced an update to shareholders regarding their proposed merger. The companies will be hosting a series of investor forums


Zacks Industry Rank Analysis Highlights: Archer Daniels Midland Company, Allion Healthcare, Nash Finch Company and The Pantry
Business Wire - January 1, 2008
CHICAGO--Zacks.com releases the latest Zacks Industry Rank. Stocks featured in this week’s analysis includes Archer Daniels Midland Company (NYSE: ADM), Allion Healthcare, Inc. (Nasdaq: ALLI), Nash Finch Company (Nasdaq: NAFC) and The Pantry, Inc. (Nasdaq: PTRY). To see the Zacks Industry Rank and the trend in earnings



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2009. AEGiS.